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ABSTRACT 
 
 
 
Comparison of Several Protocols for the Increase in Homologous Recombination in 
Normal Porcine Fetal Fibroblasts and the Application to an Actual Locus.  (May 2004) 
Gretchen Marie Zaunbrecher, B.S., University of Southwestern Louisiana; 
M.S., Texas Tech University 
Co-Chairs of Advisory Committee:  Dr. Jorge A. Piedrahita 
  Dr. James N. Derr 
 
 
Together with the advancements in animal cloning, the ability to efficiently target 
specific genes in somatic cells would greatly enhance several areas of research.  While it 
has been possible for quite some time to target specific genes in the germ cells of mice, 
the advancements in somatic cell gene targeting has been slowed for two main reasons.  
First, the finite lifespan of somatic cells, due mainly to the inability of the somatic cells to 
regenerate or maintain their telomeres, poses a major problem given the lengthy selection 
process needed to identify a targeting event.  The second problem is the overall 
inefficiency of homologous recombination.  A double strand break or introduction of 
foreign DNA into a cell can be processed either through the homologous recombination 
or non-homologous end joining pathways.  Of these two, non-homologous end joining is 
dominant in somatic cells.  A two plasmid recombination system was used to study the 
effects of the manipulation of several non-homologous end joining and homologous 
recombination pathway molecules on the rates of homologous recombination in porcine 
fetal fibroblasts.  In addition, the effect of telomerase expression, cell synchrony, and 
iv 
DNA nuclear delivery was examined.  Results indicate a strong positive relationship 
between inactivation of p53, cell synchronization, and efficient DNA nuclear delivery in 
enhancing the rate of homologous recombination.  These findings were then applied to an 
actual locus in the pig, the α1,3 galactosyltransferase gene.  Results from these 
transfections are compared to published accounts of successful targeting at this locus and 
possibilities for the differences found are discussed. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
BACKGROUND 
 
Project Overview 
 While the efficiency of targeting genes in mouse ES cells averages 
approximately 1x10-6, in somatic cells (fetal fibroblasts) targeting efficiency has been 
estimated to be 10 to 100 times less (1-5).  This low efficiency is further exacerbated by 
the high occurrence of random insertions of the transgene.  In most current targeting 
protocols, random insertion events account for the vast majority of colonies arising after 
selection.  This low efficiency combined with the finite lifespan of fibroblasts makes the 
lengthy process of targeting and identifying positive cells very difficult.  Currently, most 
targeting protocols use traditional types of enhancements to increase targeting 
efficiencies.  These enhancements include promoter/polyA trapping and 
positive/negative selection.  While there are many reports of enhancement achieved 
using these enrichment schemes, the most realistic values of enhancement of 
homologous recombination (HR) are in the range of approximately 2-5 fold with 
positive/negative selection and approximately 100-500 fold with promoter traps (4,6,7). 
 When a cell experiences a DNA double strand break (DSB), two competing 
_________________________ 
This dissertation follows the style of Nucleic Acids Research. 
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pathways are activated, the HR pathway and the non-homologous end joining (NHEJ)  
pathway.  In cells such as yeast and ES cells, the HR pathway appears to be dominant, 
while in somatic cells the NHEJ pathway appears to dominate the correction of the DSB 
(8).   
While there are many proteins involved in NHEJ, the most studied have been 
Ku70, Ku80, DNA dependent protein kinase catalytic subunit (DNA-PKcs), and the 
Rad50/Mre11/Xrs2 protein complex.  A DSB occurring at the beginning of S phase will 
be first recognized and the free DNA ends bound by the Ku70/Ku80 heterodimer.  This 
binding recruits DNA-PKcs which attracts a cascade of proteins to the sight of the break.  
The protein complex of Rad50/Mre11/Xrs2, which possess helicase and endonuclease 
activity, will bind to the free DNA ends and make them more accessible for the proteins 
involved in aligning the areas of micro-homology needed for DNA ligase IV to bind the 
ends together (9). 
 When a DSB is repaired through HR, Rad51 protein binds to the free 3’ ends of 
the DNA at the break site made by the actions of the Rad50/Mre11/Xrs2 protein 
complex mentioned above.  With the help of the many proteins in the Rad52 epistasis 
group, Rad51 interacts with undamaged DNA to search for a large area of homology.  
Once an area of homology is found, Rad51, and associated proteins, initiate strand 
exchange, strand invasion, and strand resolution resulting in the repair of the DSB (9) 
(Fig. 1).  Many studies have examined over-expression of several HR proteins and their 
effects on HR rates.  An example of this would be the studies by Vispe et al. (10) who 
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found that a two-three-fold over expression of Rad51 in Chinese Hamster Ovary (CHO) 
fibroblasts resulted in a 20-fold increase in the rates of HR.  However, there are no 
reports of studies on suppression of NHEJ pathway molecules and its affects on the rates 
of HR.  We examined different molecules including a truncated Mre11 protein.  The 
truncated protein contains the binding site for Ku70 protein (11) and can sequester Ku70 
thus inhibiting its binding to Ku80 to form a functional heterodimer.  We hypothesized 
that this in turn would cause down regulation of the NHEJ pathway.  Similarly, an RNA 
aptamer that contains a Ku70/80 specific binding sequence was also tested.  The anti-Ku 
aptamer will bind to the Ku70/80 protein complex and inhibit its binding to DNA which 
in turn should down regulate DNA-PKcs phosphorylation (12).  The final transiently 
expressed molecule was a mutated p53 protein.  This p53 mutation is identical to the 
mutation found in several cancers and is hypothesized to disrupt the p53 tetramer’s 
ability to arrest the cell cycle at late G1/early S phase therefore bypassing more quickly 
the time in the cell cycle when the NHEJ pathway is prevalent.  The HR pathway, more 
prevalent in late S phase, would then be able to repair the DSB that would normally be 
repaired by NHEJ.  Previous studies (13-16) have shown that wild type p53 interacts 
with numerous molecules involved the HR pathway including Rad51, Rad54, BLM and 
WRN (the proteins responsible for Bloom and Werner syndrome, respectively), as well 
as stalled replication forks.  In addition, there have been several reports of inactivated 
p53’s ability to enhance HR in a variety of mammalian cells (17-21).  The mutation 
proposed corresponds to the proposed binding site found for p53 and Rad51 (13).  
Theoretically, the transiently expressed dominant negative mutant p53 molecule should 
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allow continuation of the cell cycle and an increase in the availability of Rad51 which, in 
turn, should result in an increase in the rates of HR. 
HR NHEJ 
 
Figure 1.  Schematic of the two pathways to repair a DSB occurring during the S phase 
        of the cell cycle. 
 
 In addition to testing modifiers of the NHEJ and HR pathways we tested the 
effect of telomerase expression, cell synchrony, and nuclear delivery of DNA on HR.  
While there seems to be an association between telomerase expression and the rate of 
HR (22-24) there has not been a well-controlled study designed to quantify this 
relationship.  Other parameters that may influence the rate of HR are cell synchrony and 
the timing of DNA entry into the nucleus.  Unlike NHEJ, which occurs early in the S 
phase of the cell cycle, HR occurs late in the S phase.  Yet commonly used targeting 
Ku70/Ku80 Ku70/Ku80 
1) 
3) 
2) 
4) 
DNA-PKcs DNA-PKcs 
Rad50/Mre11/XRS2
DNA-PKcs DNA-PKcs 
Rad50/Mre11/XRS2 
DNA Ligase IV 
Rad50/Mre11/Nbs1
1)
Rad50/Mre11/Nbs1 
R
ad51 
2)
R
ad513)
Rad52 Epistasis Group Proteins
4)
5)
 5
vectors are, to a large extent, excluded from the nucleus until nuclear envelope 
breakdown occurs during the M phase of the cell cycle.  After these protocols are tested, 
the most promising ones are used to target an actual locus, the α1,3 galactosyltransferase 
gene. 
 
Pronuclear Microinjection 
 The first methods for introducing foreign DNA into mammalian cells to produce 
a transgenic animal was by pronuclear microinjection (25,26).  This technique relies on 
DNA delivery to the male and/or female pronuclei of the newly fertilized oocyte.  Small 
amounts (100-1000 copies) of DNA constructs are injected into the pronuclei and the 
resulting offspring is born (Fig. 2).  One major problem with this technique is the 
development of mosaics.  Mosaics occur when the transgene does not enter the genome 
until after several rounds of cell divisions have occurred, therefore, the resulting 
offspring does not contain the transgene in every cell of its body.  Analysis can show if 
the transgene was incorporated into the host’s genome, how many copies, and in what 
order (head to tail concatamers).  The identified transgenic animals, called founders, are 
used to produce animals that are non-mosaic transgenics.  These F1 offspring are used 
for further experiments including testing to determine if the transgene is active in the 
animal and whether it elicits the expected response.  While pronuclear injection has 
served the genetic world, and especially the mouse genetic world, there is a major 
problem in this technology in that one is severely limited in the range of genetic 
modifications available.  A few of the useful manipulations available to pronuclear 
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injection include:  gain of function, over-expression of a transgene that will either up 
regulate a physiological process or, down regulation of proteins through a dominant 
negative mechanism, ribosymes, or anti-sense RNA (27-29).  Finally, there is the ability 
to perform cell ablation experiments to determine cell lineages.  (30) 
 
 
Figure 2.  Schematic of microinjection into the male pronucleus of the oocyte [adapted    
from Hogan et al. (31)] 
 
 
ES Cells, ES-Like Cells, Targeting, and Chimeras 
 
 In contrast to pronuclear injection, more detailed and precise work could be 
achieved with targeted mutations of particular genes.  With the development of 
embryonic stem (ES) cell technology targeting techniques could be used.  In 1981, two 
groups derived pluripotent cells from the inner cell mass (ICM) of mouse blastocysts 
(32,33).  These ES cells were unique in that they could, with proper supplementation, 
grow in culture indefinitely and maintain both their normal karyotype and 
undifferentiated state.  However, given the proper stimulus, ES cells could be driven in 
vitro to develop into various cell types (for review see 34,35)  ES cells were first used 
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for early development and cell lineage studies until 1984 when Bradley et al. (36) 
demonstrated the ability of ES cells to colonize the germ line of chimeric mice produced 
from the injection of the ES cells into donor blastocysts.  In 1987, Thomas and Capecchi 
(37) were the first to demonstrate the ability to introduce a targeted mutation in ES cells 
through homologous recombination (HR) of the hypoxanthine phosphoribosyl 
transferase (HPRT) gene.  Transgenic ES cells, usually derived from the inbred mouse 
strain 129 or its substrains, are injected into developing blastocysts, usually from the 
BALB/c strains.  To aid in the identification of chimeras the two strains have different 
coat colors.  The resulting offspring (F0) should have both strains’ cell types in all tissues 
including the germline.  To test for germline transmission the F0 mice are bred to the 
same strain as the blastocyst donors.  The resulting offspring (F1) will either be purebred 
blastocyst donor strain or will be a full hybrid of the ES cell and blastocyst donor strains.  
If the transgene is not detrimental to the animal and follows normal Mendelian genetics, 
one half of the hybrids will not contain the transgene while the other half will be 
heterozygous for it.  Diagnostic tests such as Southern blot analysis are then performed 
to determine which hybrid F1 contains the transgene.  Once these animals are identified, 
crossing strategies will ultimately result in an animal homozygous for the transgene.  
Alternatively, due to the proliferative nature of ES cells, F1 offspring ES cells can be 
used for a second round of targeting using a second selectable marker and the 
appropriate precautions followed by another round of blastocyst injection, F0, and F1 
offspring to yield a homozygous transgenic mouse (Fig. 3). 
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Figure 3.  Generation of transgenic mice from targeted ES cells. [Adapted from Prelle 
       et al. (38)] 
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 Another class of pluripotent cells was soon developed from the urogenital ridge 
of developing fetuses.  These primordial germ cells (PGCs) or embryonic germ (EG) 
cells share many of the characteristics of ES cells including high nuclear: cytoplasm 
ratio, growth in compact multilayer colonies, alkaline phosphatase activity, highly 
conserved epitope markers such as stage specific embryonic antigen-1 (SSEA-1) and 
germ line-specific transcription factor Oct-4, high levels of telomerase, ability to 
maintain stable karyotypes and remain undifferentiated in culture, and the ability to 
colonize the germ line in chimeras (39-44).  With this success of ES, EG, and ES-like 
cells in mice, an intense effort was directed toward developing pluripotent embryonic 
cell lines from livestock species. 
 In cattle, undifferentiated cells have been isolated from all stages of embryonic 
development from 16-cell to hatched blastocyst.  Yet, despite exhaustive attempts there 
has only been limited success in long term proliferation of undifferentiated bovine ES 
cells (44-47).  One group was able to grow several ES-like cell lines for more that 50 
passages and still maintain pluripotency.  Pregnancies were established by nuclear 
transfer using these cells at a lower passage number.  However, all pregnancies were loss 
before day 60 of pregnancy due to incomplete placental development (48).  In addition, 
various attempts at making germ line chimeras from ES or ES-like cell lines have failed 
(47).  Pluripotent bovine PGCs have been isolated and grown for short periods of time 
successfully (44,49-51).  One healthy calf was born after the re-cloning of nuclear 
transfer embryos made from PGC karyoplasts.  But while early attempts at nuclear 
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transfer using freshly isolated PGCs were unsuccessful, later attempts have resulted in 
viable offspring (52,53). 
 In sheep, all attempts at isolating and growing undifferentiated ES or ES-like 
cells for more that a few passages have failed (for review see 38,54).  While attempts to 
produce germline chimeras have failed, nuclear transfer of differentiated ICM 
outgrowths have resulted in live lambs (55-57). 
 The livestock species studied the most has been the pig.  Undifferentiated ICM-
derived cell isolation, while difficult in this species, has been achieved by few (58-62).  
Most of these cell lines have been grown for extended periods of time and maintain most 
mouse ES cell characteristics.  However, there has been no reported chimeric germ line 
transmission using porcine ES cell lines (63).  Undifferentiated porcine PGCs have been 
isolated and grown, in the correctly supplemented media, for prolonged periods of time 
(64,65).  Some of these were transfected with transgenes and injected into blastocyst to 
yield live chimeric piglets.  While the different transgenes were detected in several 
tissues, none were found in the germline (64,66). 
 
Cloning Somatic Cells 
 Because of the difficulties in producing viable ES or ES-like cell lines the 
advancements of transgenics in livestock has been significantly hindered.  However, 
with the production of Dolly, a viable lamb resulting from the transfer of a nucleus from 
a somatic cell to an enucleated oocyte, the use of somatic cells as carrier cell lines to 
produce a transgenic animal could be realized (67).  Cloning involves the addition of 
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somatic cell nuclei (i.e. fibroblast) into the perivitelline space of an enucleated oocyte.  
An electrical pulse is used to cause the fusion of the cell to the oocyte.  Following 
fusion, the oocyte is activated by electrical or chemical means and the oocyte to begins 
development.  The embryo is transferred into a recipient at the correct time of embryo 
development (i.e. with or without prior culture) and cycle of recipient (variable between 
species) (Fig. 4) (68,69). 
 
Enucleated Oocyte
Donor Cell
Enucleation
Mature Oocyte 
Electrofusion
Developing Embryo 
Reconstructed Embryo
 
Figure 4.  Schematic of nuclear transfer.  After enucleation of the mature oocyte and 
        fusion with a donor cell nucleus, the reconstituted embryo is capable of 
        normal development.    
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 There are many advantages of cloning over that of pronuclear injection and 
chimeras.  The most obvious is that every cell of the resulting transgenic animal contains 
the transgene, this dramatically reduces both the analysis and time involved in producing 
a completely transgenic animal.  However, there are also many pitfalls in this 
technology.  The efficiency of cloning livestock species is very low due to high embryo 
loss, developmental problems, and to a lesser extent, post-parturition losses (67,70).  
This is further exaggerated with the inefficiencies of gene targeting in somatic cells.  The 
main reasons for this inefficiency are the finite life span of the fibroblasts used in 
cloning and the inefficiency of these cells to undergo specific genetic changes.  
However, cloning of targeted livestock fibroblast was successfully accomplished with 
the birth of sheep, targeted at the COL1A1 locus.  This demonstrated that it was indeed 
possible to make the considerable manipulations needed for targeting, and still have the 
capability of producing viable offspring (70).  Most recently, three groups (71-73) have 
reported successful targeting of the α1,3 galactosyltransferase (GT), this gene encodes 
for an enzyme which is responsible for adding a carbohydrate onto the epithelial cells of 
blood vessels that cause hyperacute rejection when introduced to antibodies present in 
human blood (74).  In addition, Phelps et al. (75) have reported the generation of the first 
homozygous α1,3 galactosyltransferase null pig through a spontaneous mutation of their 
GT+/- cell line.  Yet, HR in livestock somatic cells remains a formidable task and to date 
all targeted genes have used promoter trap enrichment protocols requiring expression of 
the target gene.  Methods for enhancing homologous recombination in somatic cells, 
therefore, would facilitate the development of transgenic livestock.     
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Experimental Molecules 
Mre11/Rad50/Xrs2(Nbs1) Protein Complex 
 Mre11, Ku70/80, and p53 were selected for manipulation and analysis.  Mre11 is 
an 80kDa multifunctional protein that forms the central binding core of the 
Rad50/Mre11/Xrs2 protein complex.  Mre11 possesses 3’ to 5’ double stranded 
(ds)DNA exonuclease and both single stranded  (ss)DNA and dsDNA endonuclease 
activities.  The different nuclease activities are structure specific in that the dsDNA 
exonuclease activity is only active in substrates containing blunt or 5’ overhangs, and is 
much less active with 3’ overhangs (76-80).  In addition, the binding of Mre11 to various 
repair molecules affects the nuclease ability of Mrell in a species specific manner (81).  
Studies by de Jager et al. (82) and Chen et al. (83) have shown that the Mrell complex 
preferentially binds to the ends of linear DNA molecules.  The second member of the 
Mre11 complex is the Rad50 protein. Rad50 is an approximately 150kDa ATP-
dependent protein whose likely function is to help bring the DNA ends together and hold 
them in loose proximity for their subsequent repair.  This function helps to facilitate the 
search for short and long regions of sequence homology in the recombining DNA 
templates, which is crucial for DSB repair in both NHEJ and HR.  This close proximity 
of the DNA ends also helps to stimulate DNA ligase activity.  Additionally, the 
association acts as a bridge connecting the broken chromatid and its sister so that there 
won’t be separation between the two.  Finally, the position of Rad50 on the DNA ends 
helps to protect the DNA ends from the nuclease activities of Mre11 (81-84).  The final 
protein in the Mre11 complex is the Xrs2 protein (yeast) or the Nbs1 protein (vertebrate 
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homologue).  Because of the divergent homologies between the yeast and vertebrate 
proteins, a defined function has been elusive.  However, there is a Mre11 binding site on 
the extreme carboxy terminus of Nbs1 and a Nbs1 binding site on the amino terminal 
half of the Mre11 protein (85). 
 Studies examining the distribution of the Mre11 complex within the cell show 
homogeneous distribution within the nucleus in resting and undamaged cells, but 
association in sites of DNA damage within 30 minutes of treatment with genotoxins to 
form nuclear foci of Mre11 complexes (86,87).  Interestingly, only agents that form 
DSBs show Mre11 foci while other DNA damaging agents such as UV light do not 
(87,88).  Evidence has accumulated suggesting a role of the Mre11 complex in 
replication fork DSB repair mechanisms.  Studies by Costanzo et al. (89) have shown 
that cells with non-functional Mre11 complexes exhibit higher rates of DSBs during 
replication.  These results shed light on the reasons why Mre11 foci are seen in 
undamaged S phase cells.  The most probable role of Mre11 complexes during 
replication is to prevent DSBs by resolving hairpin loops in DNA that tend to stall 
replication forks and thus form DSBs (81). 
 The role of the Rad50/Mre11/Nbs1 complex in repairing DSBs is controversial.  
In Saccharomyces cerevisiae Rad50 and Mre11 proteins are essential for DSB end 
joining in the NHEJ pathway (90,91)  but in Schizosaccharomyces pombe they have no 
role in DSB repair (92).  In higher eukaryotes it is difficult to access the role of the 
complex because deletions of either Mre11 or Nbs1 lead to loss of functions essential for 
normal cell growth (93-95).  Natural human mutations of Nbs1 and Mre11, in Nijmegen 
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breakage syndrome and a variant of ataxia telangiectasia respectively, have been shown 
to be sensitive to radiation, but do not appear to have defects in DSB repair itself (96-
98).  Huang and Dynan (99), using cell free end-joining systems, have shown a 
requirement for the Rad50/Mre11/Nbs1 complex in mammalian DNA NHEJ pathway.  
Taken together, the Mre11 complex is most likely involved in DSB repair in both NHEJ 
and HR but possibly plays a minor role in helping to keep the two DNA ends together 
for the repair machinery to function properly. 
 
Ku70/80 Protein Complex 
 The second molecule investigated is the Ku70/80 heterodimer protein complex.  
Much of what is know about the NHEJ pathway molecules have been from the study of 
yeast and mammalian cells lacking in various NHEJ and HR pathway molecules.  In 
2001, Walker et al. (100) reported the crystal structure of the Ku heterodimer and helped 
to clarify the suspected roles of the Ku70/80 heterodimer.  Ku has been shown to bind 
tightly and specifically to a variety of DNA ends including blunt ends, 5’ and 3’ 
overhangs, as well as hairpins (101,102) suggesting that Ku70/80 is the molecule that 
initially binds to the DNA ends of a DSB and recruits DNA-PKcs.  In binding, Ku 
protects the DNA ends from excessive nuclease degradation and also helps to align the 
two broken ends of DNA.  Ku may also play a role in targeting DNA DSBs to 
appropriate sites for repair (103).  Finally, there is strong evidence that Ku protein plays 
an important role in telomere maintenance (104).  
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p53 Protein 
 The final molecule investigated is the p53 molecule.  p53 is a complex, multi-
functional protein.  One important physiological function is to curb cell cycle 
progression or induce apoptosis following certain types of DNA damage.  Results of 
various experiments with inactive p53 suggest that p53 protects the cell from genomic 
instability.  In the event of DNA damage from harmful agents, introduction of nucleases 
into the nuclei, or even DNA transfection, p53 accumulates and blocks entry into the S 
phase of the cell cycle.  This delay at G1 will continue until repair of the damaged DNA 
has occurred or, if the damage is too extensive, p53 will trigger apoptosis and destroy the 
cell (105-107).  However, when cells are defective in p53 there is no arrest at G1.  
Studies by Livingstone et al. (108) have shown that a large fraction of p53 negative 
mouse embryo fibroblasts showed aneuploidy at passage three in culture.  In addition, 
Harvey et al. (109) found a higher incidence of cells with abnormal chromosome 
numbers in mouse embryonic fibroblasts heterozygous for an inactive p53 allele but not 
until passage twenty five.  However, more recent work by Bunz et al. (110) have shown 
that the precise inactivation of the p53 gene by HR does not result in aneuploidy in 
human colon cancer cells and human fetal lung fibroblasts.  However, they did detect a 
slight trend to tetraploidy.  They concluded that p53 inactivation alone is not the cause of 
aneuploidy, but the absence of p53 can exacerbate pre-existing tendencies toward 
chromosome instability. 
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Targeting Plasmid Design 
 The ability to precisely modify a gene through targeting is a powerful tool and 
enables the researcher to study a multitude of phenomena (111,112).  However, despite 
the many applications of targeting, there are basically two types of targeting vectors used 
in gene targeting, the insertion vector or O-type and the replacement vector or Ω-type.  
The O-type vector is linearized within an area of homology to the target gene.  
Incorporation will result in the duplication in the endogenous gene of the homologous 
DNA present in the vector as well as the insertion of the plasmid backbone.  The Ω-type 
vector is linearized outside the area of homology and incorporation results in only the 
replacement of endogenous sequences with the “same” exogenous sequence from the 
targeting vector, usually flanking a selectable marker (Fig. 5).  While insertion type 
vectors tend to yield higher recombination rates, the possible problems with the addition 
of the exogenous plasmid DNA can be avoided using the replacement vector.  Therefore, 
most laboratories use the replacement vectors, with the addition of enrichment schemes, 
in their targeting protocols (113). 
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Figure 5.  Schematic of the two types of homologous recombination.  A)  Insertion or 
        O-type homologous recombination B)  Replacement or Ω-type homologous 
         recombination.  (exo=fragment of exon 2) 
 
 
Promoter Trap Enrichment 
 The enrichment schemes most used today are the promoter trap, polyA trap, and 
positive/negative selection (PNS).  The most popular enrichment scheme is the use of a 
promoter trap in the targeting construct.  The promoter region of the selectable marker of 
a replacement vectors is removed and the marker is inserted inside an exon, in frame 
with the coding region.  When incorporation occurs and the targeted gene is transcribed 
and translated, a fusion protein of the target gene and selectable marker results.  The 
 19
transformed cells can then be selected with the appropriate selection media and the 
targeted cells recovered.  However, there are some problems with this technique.  While 
promoter trapping enriches the targeting system by approximately 100 fold (6) there is 
still the possibility of the target construct randomly inserting in frame into another active 
gene therefore giving a false positive.  In addition, the fused protein may inhibit the 
selectable marker’s ability to function correctly.  Finally, only actively expressing genes 
are available for targeting with this method.  To help prevent problems with fused 
protein interference with the selectable marker expression, most protocols involve the 
addition of an internal ribosomal entry site upstream of the selectable marker. 
 
Internal Ribosomal Entry Site 
During normal eukaryotic translation, various initiation factors assemble initiator 
tRNA, 40S, and 60S ribosomal subunits into a functional 80S ribosome at the initiation 
codon of mRNA.  In picornaviruses such as encephalomyocarditis virus (EMCV), 
Theiler’s murine encephalomyelitis virus (TMEV), and foot-and-mouth disease virus 
(FMDV) an internal ribosomal entry site (IRES) is responsible for the initiation of 
mRNA translation (114).  The EMCV, most commonly used in targeting vectors, is an 
approximately 400 nucleotide sequence 5’ of the initiation codon.  The RNA forms a 
distinct secondary structure that consists of four major structural domains.  No 
significant sequence or structural similarities have been found between IRES’s of 
unrelated viruses and studies have shown various and unique requirements for each class 
of IRES (114). 
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 In addition, Macejak and Sarnow in 1991 (115) discovered the first cellular IRES 
in the 220 nucleotide long 5’ untranslated region of the immunoglobulin heavy chain 
binding protein mRNA.  Since then, many IRES-like acting sequences have been found 
in eukaryotic cells as diverse as yeast to mammalian cells (116).  The most probable 
reason for the presence of an alternative method of translation for specific genes is likely 
as a safety mechanism to ensure the cell’s ability to produce proteins during times of 
impaired cap-dependent translation.  Such times include physiological impairment of the 
cap mediated translation during mitosis, quiescence, differentiation, and stress or when 
proteolytic enzymes cleave necessary initiation factors during apoptosis or viral 
infection (116,117).  
 The use of the EMCV IRES element was first used by Ghattas et al. in 1991 
(118).  The dicistronic expression vector was introduced into chick embryos and 
successfully translated both β-galactosidase and the chloramphenicol acetyltransferase 
gene (CAT).  Since then it has been used extensively in the field of gene trapping and 
has helped in the discovery of countless new genes (119).  In addition, the presence of an 
IRES in a promoterless expression vector has been shown to increase the efficiency of 
trapping novel genes by as much as 15 fold (119).  This enhancement is mainly due to 
two reasons.  First, because the IRES allows for cap-independent translation, the 
downstream protein is not fused with the protein from which the promoter drives.  
Second, when using a promoterless construct, normally the exogenous gene must be in 
frame with its fused protein.  This is not a requirement due to the presence of the IRES.  
Therefore, the properly designed plasmid must only integrate into an actively transcribed 
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gene for correct and detectable expression of the gene of interest to occur, even in very 
low expressing genes (119). 
 With the success of IRES in gene trapping Wood et al. (120) incorporated the 
same concept into targeting vectors.  Placing an IRES 5’ of the promoterless selectable 
marker allowed for similar enhancement in targeting genes in ES cells as it did in 
trapping genes.  Research has shown that IRES containing constructs are active in a 
variety of loci that exhibit various levels of expression and have been shown capable of 
being transmitted successfully through the germline (121,122).  
 
PolyA Trap Enrichment 
 The polyA trap enrichment protocol can be useful in targeting non-expressing 
genes.  This method relies on trapping the target gene’s polyA signal.  The selectable 
marker is driven by its own promoter but lacks a polyA signal.  Upon incorporation into 
the target sequence, the selectable marker will be expressed.  Because of the high 
background of random targets due to the polyA trap plasmid incorporating in any gene, 
the enrichment with this protocol is not as high as the others, and is seldom used (4,6,7) 
 
Positive/Negative Selection Enrichment 
 A positive/negative selection protocol involves the use of either the positive 
selection protocols mentioned above with the addition of a negative selectable marker 
outside the area of homology.  It has been shown that homologous recombination will 
result in incorporation of only the homologous exogenous DNA including the flanked 
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positive selectable marker and will exclude the negative selectable marker.  However, 
random integration of the construct will result in the incorporation of the entire targeting 
construct including the negative selectable marker.  Proper selection techniques should 
result in cells that survive only if the positive marker is active and the negative selectable 
marker is inactive or not present.  Problems arise with this technique when random 
incorporation results in the inactivation of the negative selectable marker and therefore 
the overall enrichment usually received from the use of PNS is about two to five fold (4).  
 
Non-Traditional Enhancements 
Telomerase
 Telomeres are specialized DNA/protein structures located at the ends of 
chromosomes.  Many proteins have been found to associate with telomeres and are 
thought to act as protective caps to prevent chromosome fusion and to distinguish the 
chromosome ends from DSBs in need of repair.  Surprisingly, many of the proteins 
involved in NHEJ such as Ku70/Ku80, DNA-PKcs, DNAligaseIV/XRCC4, and 
Rad50/Mre11/Nbs1 have been shown to have intimate contact with telomeres.  Studies 
by d’Adda et al. (123) have shown that Ku70/80 and DNA-PKcs are bound to telomeres 
in both telomerase positive and ALT cells, cells that maintain telomeres through HR 
mechanisms.  In addition, using KU80-/- or Ku70-/- mouse cells they have shown that 
both exhibit dramatically shorter telomeres then Ku+/+ strains and that Ku+/- strains 
show an intermediate shortening.  Finally, they found that null mutations of either 
component of the XRCC4/DNA LigaseIV complex showed no shortening of telomeres.  
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Alternatively, Hande et al. (124) used scid mice, lacking in DNA-PKcs, to show that 
these mice exhibited longer telomeres than their wild type genetic match controls.  It has 
been shown previously that the Ku complex and essentially all of the cellular TRF1, a 
mammalian telomere binding protein, localized at the telomere (125).  Hsu et al. (126) 
expanded on this and found that the Ku complex does not bind to the telomere sequence 
directly but to the TRF1 which in turn binds the telomere.  Peterson et al. (127) have 
shown that the Ku70/80 complex interacts with a stem loop structure present on the 
telomerase RNA gene product.  The over-expression of this structure in normal cells 
resulted in telomere shortening and loss of telomeric silencing, phenotypes similar to 
those seen when the Ku complex is dysfunctional (128).  Over-expression of the stem 
loop structure in cells lacking either Ku70 or Ku80 had no impact on telomere length 
and only addition of both complex components resulted in the reverting back to 
shortened telomeres and lack of telomeric silencing.  They could not demonstrate, 
however, if the stem loop interacted directly with the Ku complex.  The model proposed 
from this work is that the stem loop, which does not appear to directly participate in 
catalysis telomere addition, interacts with the telomerically bound Ku which helps to 
keep telomerase in close proximity to the chromosome end.  Ku could then pass the 
telomerase to proteins such as Cdc13p and/or Est1p, which have been implicated in 
telomerase recruitment and are required for telomere addition in vivo.  Alternatively, the 
interaction between the stem loop and Ku could activate telomerase after it has been 
brought to the telomere. 
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 Evidence has shown that the Ku complex is the primary sensor of DSBs during 
NHEJ and the binding of the complex to DNA triggers the activation of the protein 
cascade needed for repair of the DSB (9,102,129,130).  Evidence has also shown that 
cells high in telomerase activity such as ES cells, regenerating liver cells, and Fanconi’s 
anemia cells show higher rates of HR and lower rates of NHEJ then somatic cells not 
expressing telomerase (1-5,22-24).  Could the sequestering of Ku by the 
telomeres/telomerase cause a shift in the repair of DSB from NHEJ to HR?  To date, 
there have been no reports on the relationship between the ectopic expression of 
telomerase and the rates of HR in normally telomerase negative somatic cells.   
  
Nuclear Localization Signal 
 More efficient delivery of the transgene to the nucleus would decrease time in the 
cytoplasm where it could be degraded.  In addition, rapid delivery to the nucleus allows 
for longer exposure of the transgene to the HR machinery than if cell division and 
nuclear membrane breakdown is required.  Studies of nuclear localization of cytoplasmic 
proteins to the nucleus have shown that these proteins possess a nuclear localization 
signal (NLS) that interacts with cytoplasmic proteins which transport the proteins to the 
nucleus via a nuclear pore complex (NPC) (131).  In addition, Vacik et al. (132) has 
shown that plasmid DNA containing a 366bp sequence from simian virus 40 (SV40) 
origin of replication and early promoter were bound by cytoplasmic transcription factors 
that contain an NLS sequence, and were transported into the nucleus through the NPC.   
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Synchronization 
 An alternative method to enhance HR would be to have the majority of the cells 
synchronized at a point in the cell cycle, mid-late S phase, where HR is favored over 
NHEJ.  It is well established in mammalian cells that compounds that inhibit replication 
are strong inducers of sister chromatid exchange, gene amplification, and HR (133-137).  
In addition, Saintigny et al. (138) showed repair of DSBs during replication fork stalling 
during early S phase to be associated with NHEJ and breaks occurring at the latter stage 
of S phase to be corrected by HR.  While studies by Lundin et al. (139) did not show 
DSB present when cells were arrested with thymidine, they did indicate that HR of the 
HPRT gene in Chinese hamster cell lines was the sole mechanism responsible for 
rescuing cells arrested in S phase by thymidine incorporation.  However, a comparison 
of HR rates between normal and thymidine blocked cells has not been reported. 
 
Objectives 
 Even though there have been several reports of gene targeting in livestock 
somatic cells, the efficiencies are still low enough to discourage the general use of this 
technology.  Therefore, any improvement in the area of targeting would help to make it 
more accessible to investigators.  The overall goal of the following experiments was to 
develop a highly efficient protocol for gene targeting in somatic cells.  Using a two 
plasmid recombination system, the effects of the addition of a truncated Mre11 protein,  
an anti-Ku RNA aptamer, or a mutated p53 protein on HR in porcine fetal fibroblasts 
was assayed.  In addition, the effects of ectopic expression of human telomerase, and the 
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interaction as well as separate effects of cell synchronicity and efficient nuclear delivery 
of DNA will also be assayed.  Finally, using the best protocol, a preliminary experiment 
using an α-1,3-galactosyltransferase targeting vector was performed to determine if the 
protocol works on an actual locus in porcine fetal fibroblasts.   
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CHAPTER II 
EFFECTS OF THE MANIPULATION OF NON-HOMOLOGOUS END JOINING 
AND HOMOLOGOUS RECOMBINATION MOLECULES ON THE RATES OF 
HR IN PORCINE FETAL FIBROBLASTS USING A TWO PLASMID 
RECOMBINATION SYSTEM 
 
INTRODUCTION 
 
 The first inbred mouse embryonic stem (ES) cells were gene targeted in 1987 
when Thomas and Cappechi (37) successfully targeted the hypoxanthine phosphoribosyl 
transferase (HPRT) gene.  Following targeting, a transgenic animal was made through 
blastocyst injection of the transgenic ES cells to form a chimeric mouse whose germ line 
contained the transgenic cells and was able to pass the transgene to the next generation, 
thus producing a transgenic animal.  Since then, gene targeting in mouse ES cells has 
become common place.  However, attempts to develop a viable, pluripotent ES cell line 
in livestock species have had little success (for review see 38,140).  With the production 
of Dolly, a viable lamb resulting from the transfer of a nucleus from a somatic cell to an 
enucleated oocyte, the use of somatic cells as carrier cell lines to produce a transgenic 
animal could be realized (67).  This possibility was further advanced with the production 
of the first gene targeted transgenic livestock species.  The birth of sheep targeted at the 
COL1A1 locus, demonstrated that it was indeed possible to make the considerable 
manipulations needed for gene targeting, and still have the capability of producing viable 
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offspring (70).  Most recently, three groups (71-73) have reported successful targeting of 
the α1,3 galactosyltransferase (GT), an enzyme which is responsible for adding a 
carbohydrate onto the epithelial cells of blood vessels that cause hyperacute rejection in 
the presence of human blood (74).  In addition, Phelps et al. (75) have reported the 
generation of the first homozygous α1,3 galactosyltransferase null pig through a 
spontaneous mutation of their GT+/- cell line.  Yet, HR in somatic cells remains a 
formidable task and to date all targeted genes have used promoter trap enrichment 
protocols, requiring expression of the target gene.     
 Many studies have looked at over-expression of several HR proteins and their 
effects on HR rates.  However, there has been no report of studies on suppression of 
NHEJ pathway molecules and its affects on the rates of HR.  Therefore, the effect of 
several molecules affecting the NHEJ pathway on the rate of HR was assayed via a two 
plasmid recombination system. 
 
MATERIAL AND METHODS 
 
Isolation of Fibroblast  Cells 
 Purebred Duroc gilts on day 35 of pregnancy were hysterectomized and the 
fetuses removed.  The head and viscera were removed and the remaining tissue was 
minced with a sterile razor blade.  The tissue was added to 10ml of 0.05% trypsin 
(Gibco) supplemented with 0.9mM potassium chloride, 0.9mM dextrose, 0.7mM sodium 
bicarbonate, 0.1mM EDTA (all from Sigma), and 20mM sodium chloride (EM Science).  
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The tissue/trypsin solution was shaken at 37ºC for 15 minutes a total of three times.  
After incubation, the supernatant was collected, pooled, and pelleted.  The cell pellet was 
resuspended in DMEM/F12 media (Gibco) supplemented with 10% fetal bovine serum 
(FBS) and 5% calf serum (CS) (both from Hyclone), 30mM sodium bicarbonate, 0.5mM 
pyruvic acid, and 2mM N-acetyl-L-cysteine (all from Sigma).  In addition, 100U 
penicillin, 100ug, and 250ng amphotericin (Gibco) were added to inhibit microbe 
growth.  The cells were placed in the appropriate number of 10cm tissue culture plates 
(Corning) and placed in a 5% CO2 incubator (Nuaire) at 39ºC, allowed to attach and 
grow to confluency and passed (1:2 or 3).  The cells were trysinized and frozen in 50% 
FBS, 40% media, and 10% DMSO (Sigma), placed in -80ºC overnight and then in liquid 
nitrogen for long time storage and future use.    
 
Plasmids 
 Two truncated puromycin acetyltransferase (puro) vectors were designed.  
Primers specific to either the pBluescript or puromycin acetyltransferase gene (puro) 
were used to generate the plasmids using a pBluescript (pBS) (Stratagene) vector 
containing a phosphoglycerate kinase-1 promoter (pgk), puro, and bovine growth 
hormone polyA sequences for the PCR template (Table 1). 
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Table 1.  PCR primers utilized for generating the two truncated plasmids 
 
Primer name    Sequence    Priming site 
 
3’ ∆ puro forward primer GTAAAACGACGGCCAG   pBluescript 
 
3’ ∆ puro reverse primer GCTTGCGGGTCATGCAC   puro gene 
 
5’ ∆ puro forward primer CCGAGTACAAGCCCACGG  puro gene 
 
5’ ∆ puro reverse primer CAGGAAACAGCTATGAC   pBluescript 
 
(all oligonucleotides (except when mentioned) were purchased from Genosys) 
 
PCR conditions for the 3’ ∆ puro plasmid were initial denaturing at 94ºC for 2 
minutes, 30 cycles of denaturing at 94ºC for 15 seconds, annealing at 62ºC for 30 
seconds, and elongation at 69ºC for 2 minutes followed by a final elongation at 69ºC for 
7 minutes.  The same conditions were used for the 5’ ∆ puro plasmid with the exception 
of the annealing temperature changed to 58ºC.  One ul of Expand High Fidelity 
polymerase mix (Roche), 20mM of each dNTP (Roche), and 1.5mM magnesium 
chloride was used.  The resulting fragments were then cloned into a pCR2.1 vector 
(Invitrogen). 
 The 3’ ∆ puro is a plasmid containing only the pgk promoter and a 3’ end 
truncated puromycin acetyltransferase gene and lacks the poly A signal (Fig. 6).  The 5’ 
∆ puro is a plasmid containing a 5’ truncated puromycin gene and the poly A signal, but 
lacks the pgk promoter (Fig. 6).  Both plasmids share approximately 580 base pairs (bp) 
of homology in the puromycin gene.  Neither plasmid is able to elicit puromycin 
resistance when transfected alone into a cell.  However, when both plasmids are 
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introduced into a cell, HR occurs via their shared homology and a fully functional 
puromycin resistant gene is formed (Fig. 6).  Cells that have undergone a successful 
recombination event will be able to survive in the presence of puromycin.  The rates of 
recombination, therefore, can be calculated by the number of puromycin resistant 
colonies that arise after selection.   
 
Puro
Puro
Puro
PolyA
PolyA
PGK
PGK
5'-Truncated PGK Puro PolyA 
3'-Truncated PGK Puro PolyA 
Functional PGK Puro PolyA
Homologous Region:  580bp
Figure 6.  Schematic of the two plasmid recombination system.  Neither the 5’ nor 3’ 
         truncated plasmids alone are able to survive in the presence of puromycin.  
         Both vectors share 580bp of homologous sequence and after HR between 
         the two plasmids, the resulting plasmid is fully functional and will allow for 
         the growth of cell colonies in the presence of puromycin. 
 
 
 The truncated Mre11 plasmid was constructed using porcine fetal fibroblast 
(PFF) cDNA as the template for primers (Table 2) designed from conserved Mre11 
sequences in the mouse (Accession# NM_018736) and human (Accession# BT_006730) 
which amplified a 408 bp product that encompasses amino acids 24-160 (based on 
mouse open reading frame [ORF]) using the following PCR conditions:  initial 
denaturing at 94ºC for 2 minutes, 30 cycles of denaturing at 94ºC for 10 seconds, 
annealing at 55ºC for 30 seconds, and elongation at 69ºC for 2 minutes followed by a 
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final elongation at 69ºC for 7 minutes.  The 408bp PCR product was then cloned into a 
pCR2.1 vector and re-amplified with the forward primer, Mre11F2, containing 
homology to the Mre1F1 plus additional NcoI and BspEI sites and the reverse primer, 
Mre11R2, containing homology to Mre11R1 plus an additional NotI site (Table 2) using 
the same PCR conditions as before except the annealing temperature was changed to 
56ºC.  The resulting 438 bp product was partially digested with NotI and NcoI (NcoI site 
235 bp within amplicon) and subcloned into a pEF/myc/nuc expression plasmid 
(Invitrogen).  
 
 
Table 2.  PCR primers utilized for generating the truncated Mre11 plasmid 
 
Primer name    Sequence   Additional cut site 
 
Mre11F1  GGATTTATGGAGAAAGATGCAG  none 
 
Mre11R1  CCACAGACATTGAACGTCCAAAG  none 
 
Mre11F2 CGCGCGCCATGGACTCCGGATTTATGGAG       NcoI & BspEI
 
Mre11R2 CGTATAGCGGCCGCCACAGACATTGAACG  NotI
 
 
 
 
An RNA aptamer was purchased from Dharmacon Research, Inc. containing the 
sequence:  A*G*G* UCGGCAUACAGAGUUCCGAAUGCGCGUAACUUCG*A*C*U.  The 
oligonucleotide was made in the stable 2’-O-ACE protected form to protect the aptamer 
from endonucleases and the (*) nucleotides possess a thioate linkage instead of 
phosphodiester bond for exonuclease protection. 
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The mutant p53 plasmid was constructed using bovine spleen RNA as a template 
for reverse transcription using the oligo dT primer.  The cDNA was then amplified using 
hemi-nested primers (Table 3) and the PCR conditions:  initial denaturing at 94ºC for 2 
minutes, 30 cycles of denaturing at 94ºC for 30 seconds, annealing at 54ºC for 30 
seconds, and elongation at 72ºC for 2 minutes followed by a final elongation at 72ºC for 
7 minutes.  The resulting fragment was then cloned into a pCR2.1 vector.  A Valine135 to 
Alanine135 point mutation was introduced following the protocol provided by Clonetech 
and the oligo from Table 3.  The mutated cDNA was then subcloned into a pDNA3 
under the control of the CMV promoter.     
 
 
Table 3.  PCR primers/oligo utilized for generating the mutated p53 plasmid 
 
Primer name             Sequence    
 
p53 forward primer   ATCCCAGGACGGTGACACC 
 
p53 reverse primer 1   ACCTGCACCAAGCAGAGGTC 
 
p53 reverse primer 2   AGGCTGAGCAGATGAAGACTCC 
 
Mutation oligo   AAGACCTGCCCAGCGCAGCTGTGGGTC 
 
(GCG is the codon that was changed) 
 
 
 
Fibroblasts were re-established from freezing and grown in the (antibiotic free) 
medium described above.  The cells were expanded until appropriate numbers were 
obtained.  At the time of electroporation, cells were trysinized, counted, and aliquotted to 
10x106 cells per treatment.  Cells were pelleted and resuspended in 0.8ml of cold F10 
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Nutrient Mixture (HAM) and placed in a 4millimeter gap electroporation cuvette.  DNA 
was delivered into the cells via electroporation (450 volts, 1 millisecond, 4 pulses). 
In all experiments, 5nM of the linearized 3’ truncated and of the circular 5’ 
truncated plasmid was used.  Five nM of the mutated p53 circular plasmid, the Ku RNA 
aptamer, or the truncated Mre11 circular plasmid was added at the time of 
electroporation.  After each electroporation, the fibroblasts were plated 1-2x106 cells per 
10cm tissue culture plate and allowed to recover and attach overnight.  Puromycin at the 
concentration of 2ug/ml was added to all plates approximately 24 hours after 
electroporation and grown under selection until puromycin resistant colonies were 
visualized.   Plates were washed with phosphate buffered saline and incubated in a 1:1 
ratio of methanol:acetone at -20ºC for 20 minutes, air dried and stained with trypan blue. 
 
Data Representation and Statistical Analysis 
 Data sets were transformed, when needed, to aid in acquiring normal distribution 
of values.  Averages of four replications were subjected to ANOVA to determine 
differences between the means of the different treatments.  If a difference was found, 
Fisher’s Least Significant Difference analysis, using SPSS software, was performed to 
determine which treatments were significantly different at the p< 0.05 level.  Results are  
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represented in average colony number of treatment groups (2 plasmids) divided by the 
average colony number of the positive control (single, fully functional puromycin 
resistance plasmid) multiplied by 100.  This value represents the percentage of colonies 
that are the result of homologous recombination.  The chart shown represents the 
frequency of HR events per treatment as compared to the control.   
 
RESULTS 
 
Effects of Truncated Mre11, Anti-Ku RNA, and Mutant p53 on the Rates of HR 
 The results of electroporations consisting of the two truncated plasmids with the 
addition of one of the repair molecules, truncated Mre11, anti-Ku aptamer, or mutated 
p53, were compared to the results from electroporations of an intact, functional 
puromycin resistant gene.  The average results of four experiments on the same cell line 
show no significant differences in HR percentages of the two plasmids between no 
treatment (control) and the addition of either the truncated Mre11 plasmid or the anti-Ku 
aptamer.  However, a significant difference (p<0.05) was found between the addition of 
the mutant p53 plasmid and all other treatment groups (Fig. 7). 
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Figure 7.  Percentage of colonies resulting from HR of the truncated plasmids with 
         5nM of the indicated treatment added at the time of electroporation.  Error 
         bars = standard error for each treatment group.  (p<0.05)   
 
 
 
DISCUSSION 
 
 Results of this study indicated that manipulation of p53 can result in the 
enhancement of HR between two truncated plasmids.  Similar results were found by 
Mekeel et al. (18) using HR correction of two mutated hygromycin cassettes in tandem 
on a single plasmid to calculate HR rates between cell lines that were either positive or 
negative in p53 activity.  The enhancement found in our system is perhaps due to the 
mutant p53’s ability to interfere with both normal p53 tetramer formation and with p53 
tetramer/Rad51 interactions.  If this were the case, the use of this mutated p53 in 
targeting protocols would increase the rates of HR by first allowing the cells to bypass 
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early S phase and also increase the availability of Rad51 in late S phase.   Tight control 
must be exerted on the transient nature of the mutated p53 due to its potential ability to 
cause aneuploidy in the transfected cells thus making the targeted cells useless for 
cloning protocols. 
 Unlike p53, no enhancement of HR was detected with either the truncated Mre11 
or the anti-Ku RNA aptamer.  Studies by Yoo and Dynan (12) have shown that the RNA 
aptamer used in our experiments was able to aggressively compete with DNA for the 
Ku70/80 heterodimer protein complex and, because of this, down regulate DNA-PKcs 
phosphorylation by 85%.  However, Yoo and Dynan (12) used cell extracts and no 
studies have looked at the relationship between this RNA aptamer and Ku protein in 
vivo.  Because no assay for DNA-PKcs phosphorylation was performed in this 
experiment, it can not be concluded that the RNA aptamer sequestered the Ku70/80 
protein in the cells as it did in the cell extracts.  Alternatively, if it did work in vivo as it 
did in vitro, 15% of the DNA-PKcs in the cell would still be phosphorylated.  This 
meager amount of activity may have been enough to allow for efficient NHEJ to occur.  
The truncated Mre11 protein studied here represents approximately the first one-fifth of 
the fully functional Mre11 protein.  This portion has been shown to bind to Ku70 protein 
via a yeast two-hybrid screen (11).  In addition, Goedecke et al. (11) found evidence that 
Mre11 and Ku70 interact naturally in mouse hybridoma cell extracts and co-localize in 
nuclei of somatic cells and the XY divalent of the mouse testis.  However, during early 
meiotic prophase only Mre11 was abundant and Ku70 was not detectable.  They 
concluded from their data that Ku70 attracts Mre11 to DSBs in order for NHEJ to occur 
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and in the absence of Ku70 Mre11 is free to participate in HR.  There have been no 
studies to determine if a protein consisting of the first one-fifth of the Mre11 inhibits 
Ku70’s ability to participate in NHEJ.  While these results do not determine if it does 
affect Ku70’s involvement in NHEJ, it does show that the truncated Mre11 does not 
enhance HR between two truncated plasmids.     
 39
CHAPTER III 
EFFECTS OF TELOMERASE EXPRESSION ON THE RATES OF 
HOMOLOGOUS RECOMBINATION IN PORCINE FETAL FIBROBLASTS 
 
INTRODUCTION 
 
 The ability to further increase HR efficiency in normal somatic cells would have 
profound effects in the advancements of transgenics.  In all successful livestock somatic 
cell gene targeting reported to date the use of promoter trap enrichment has helped to 
increase the inherently low levels of HR to that nearly equal to ES cells (70-73,141).  
While this increase is encouraging it still remains too low to be practically applicable for 
researchers.  There is an interesting phenomenon in cells with high rates of HR such as 
ES cells, regenerating liver cells, and Fanconi’s anemia cells in that they all have been 
shown to express telomerase (1-5,22-24).  Early work by Finn et al. (142) found, using 
non-functional tandem neomycin sequences, that HR frequencies were higher in 
immortal cells as compared to normal diploid cells.  In addition, Thyagarajan et al. (143) 
found that cell lyzates from immortal cells contained molecules that increased HR 
between two truncated non-functional neomycin plasmids.  More recently, studies have 
shown an intimate connection between several NHEJ pathway molecules and telomeres 
and telomerase (123-128) which could play a role of sequestering/down regulation of 
this pathway and possibly allow the HR pathway to repair DSB in telomerase positive 
cells.  However, to our knowledge, there has not been a well-controlled study designed 
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to quantify the relationship between the expression of telomerase and the increase in HR 
efficiency.  To this end normal porcine fetal fibroblasts were virally co-transfected with 
the human telomerase reverse transcriptase (hTERT)  cDNA and the green fluorescent 
protein (GFP).  The HR percentage between two non-functional puromycin plasmids in 
these cells were compared to that of the normal, non-transformed, and GFP-transfected 
controls. 
     
MATERIAL AND METHODS 
 
Plasmids and hTERT Transformation 
 Two truncated puro vectors were designed.  Primers specific to either the 
pBluescript or puro gene were used to generate the plasmids using a pBS vector 
containing a pgk, puro, and bovine growth hormone polyA sequences for the PCR 
template (Table 1). 
PCR conditions for the 3’ ∆ puro plasmid were initial denaturing at 94ºC for 2 
minutes, 30 cycles of denaturing at 94ºC for 15 seconds, annealing at 62ºC for 30 
seconds, and elongation at 69ºC for 2 minutes followed by a final elongation at 69ºC for 
7 minutes.  The same conditions were used for the 5’ ∆ puro plasmid with the exception 
of the annealing temperature changed to 58ºC.  One microliter (ul) of Expand High 
Fidelity polymerase mix, 20mM of each dNTP, and 1.5mM magnesium chloride was 
used.  The resulting fragments were then cloned into a pCR2.1 vector. 
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 The 3’ ∆ puro is a plasmid containing only the pgk promoter and a 3’ end 
truncated puromycin acetyltransferase gene and lacks the poly A signal.  The 5’ ∆ puro 
is a plasmid containing a 5’ truncated puromycin gene and the poly A signal but lacks 
the pgk promoter.  Both plasmids share approximately 580bp of homology in the 
puromycin gene.  Neither plasmid is able to elicit puromycin resistance when transfected 
alone into a cell.  However, when both plasmids are introduced into a cell, HR occurs via 
their shared homology and a fully functional puromycin resistant gene is formed (Fig. 6).  
Cells that have undergone a successful recombination event will be able to survive in the 
presence of puromycin.  The rates of recombination, therefore, can be calculated by the 
number of puromycin resistant colonies that arise after selection.   
Day 57 PFFs were virally transfected with green fluorescent protein (GFP) alone 
or with GFP plus human telomerase reverse transcriptase (hTERT) using procedures 
described elsewhere (144).  Functional telomerase activity in the fibroblasts was 
determined using the TRAPeze Telomerase Detection Kit (Intergen).  A population 
doubling experiment was conducted comparing the GFP and GFP/hTERT expressing 
cells.  Population doublings were calculated using the formula:  [log10(# cells 
harvested)- log10(# cells seeded)] x 3.3219.  In addition, karyotype analysis was 
performed on both sets of cells.  Metaphase spreads were prepared from colchocine 
arrested cells stained with 4’,6-diamidino-phenylindole.  Digital images were acquired 
and analyzed using CYTOVISION software (Applied Imaging Systems). 
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Fibroblast Cell Culture and Transfections 
 Pure bred Duroc gilts on day 57 of pregnancy were hysterectomized and the 
fetuses removed.  The skin was removed from the hind leg of the fetuses and the muscle 
was minced.  The tissue was added to 10ml of 0.05% trypsin supplemented with 0.9mM 
potassium chloride, 0.9mM dextrose, 0.7mM sodium bicarbonate, 0.1mM EDTA, and 
20mM sodium chloride.  The tissue/trypsin solution was shaken at 37ºC for 15 minutes a 
total of three times.  After incubation, the supernatant was collected, pooled, and 
pelleted.  The cell pellet was resuspended in DMEM/F12 media supplemented with 
10%FBS and 5%CS, 30mM sodium bicarbonate, 0.5mM pyruvic acid, and 2mM N-
acetyl-L-cysteine.  In addition, 100U penicillin, 100ug, and 250ng amphotericin were 
added to inhibit microbe growth.  The cells were placed in 10cm tissue culture plates, 
incubated in a 5% CO2 incubator at 39ºC, allowed to attach and grow to confluency and 
passed (1:2 or 3).  The cells were then trysinized and frozen in 50% FBS, 40% media, 
and 10% DMSO for long time storage and future use.    
Cells were re-established from freezing and grown in the (antibiotic free) media 
described above.  The cells were expanded until appropriate numbers were obtained.  At 
the time of electroporation, cells were trysinized, counted, and aliquotted to 10x106 cells 
per treatment.  Cells were pelleted and resuspended in 0.8ml of cold F10 Nutrient 
Mixture (HAM) and placed in a 4millimeter gap electroporation cuvette.  DNA was 
delivered into the cells via electroporation (450 volts, 1 millisecond, 4 pulses). 
In all experiments, 5nM of the linearized 3’ truncated and of the circular 5’ 
truncated plasmid was used.  After each electroporation, cells were plated 1-2x106 
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fibroblasts per 10cm tissue culture plate and allowed to recover and attach overnight.  
Puromycin at the concentration of 2ug/ml was added to all plates approximately 24 
hours after electroporation and the cells were grown under selection until puromycin 
resistant colonies were visualized.   Plates were washed with phosphate buffered saline 
and incubated in a 1:1 ratio of methanol:acetone at -20ºC for 20 minutes, air dried, 
stained with trypan blue, and the colonies counted. 
 
Data Representation and Statistical Analysis 
 Data sets were transformed, when needed, to aid in acquiring normal distribution 
of values.  Averages of three replications were analyzed by ANOVA to determine 
differences between the means of the different treatments.  If a difference was found, 
Fisher’s Least Significant Difference analysis, using SPSS software, was used to 
determine which treatments were significantly different at the p< 0.05 level.  Results are 
presented as average colony number of treatment groups (2 plasmids) divided by the 
average colony number of the positive control (single, fully functional puromycin 
resistance plasmid) multiplied by 100.  This value represents the percentage of colonies 
that are the result of homologous recombination.  The chart shown is the frequency of 
HR events per treatment as compared to the control.   
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RESULTS 
 
Porcine Fetal Fibroblasts Express Functional hTERT 
 An hTERT expression plasmid was virally transfected into PFFs and was shown 
to stably express an active telomerase protein via the TRAPeze Telomerase Detection 
Kit.  Only cell extracts from hTERT transfected cells exhibited the expected laddering 
pattern after PCR while all other samples, GFP alone transfectants and heat inactivated 
samples, showed only internal control bands (Fig. 8).   
 
Expression of hTERT Does Not Extend the Lifespan of Porcine Fetal Fibroblasts 
 A population doubling experiment was also undertaken to determine if this active 
human telomerase could extend the natural life span of the fibroblasts.  To enable 
selection, a GFP expression vector was co-transfected with the hTERT vector.  As a 
control, GFP only transfected cells were grown and compared to the GFP/hTERT cells.  
A summary of growth is presented in Figure 9.  The human telomerase expressing cells 
became senescent after approximately 21 doublings while the GFP expressing cells 
continued dividing to at least 39 population doublings at the end of the experiment.  The 
average number of days between each population doubling was 6 days for the hTERT 
cells and 4 days for the GFP cells.  However, the GFP cells continued to grow robustly 
while the hTERT cells showed dramatically slower growth at the end of the experiment.  
As seen in Figure 9, the number of days between each population doubling was still 
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close to the average for the GFP cells at 3 days while the hTERT cells were close to 
three times longer than their average days between population doublings at 16 days.  
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Days Per Population Doubling hTERT vs GFP
Figure 9.  Comparison of the days between population doublings between hTERT/GFP 
         and GFP only expressing cells.  GFP only expressing cells continued to 
         have close to average (4) days between population doublings at the end of 
         the experiment while the hTERT/GFP expressing cells had close to three 
         times longer interval between population doublings as the average (6).  
 
 
 
Expression of hTERT Does Not Cause Aneuploidy in Porcine Fetal Fibroblasts 
 Metaphase spreads of the hTERT expressing cells showed 25% of the cells with 
normal diploid cells (2n=38), 25% of cells with variable number of chromosomes (not 
tri- or tetraploid), and 50% tetraploid cells.  While all the GFP cells contained small 
extra fragments that did not resemble normal chromosomes, 15% were determined to be 
diploid, 50% were triploid with extra small fragments, and 35% aneuploids of variable 
number with all being over 57 chromosomes.  Figure 10 shows a representative slide of 
a normal karyotype from the hTERT expressing cell line. 
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Figure 10.  Metaphase spread of an hTERT cell showing normal karyotype 2n=38. 
 
 
Expression of hTERT Does Not Increase HR Efficiency in Porcine Fetal Fibroblasts 
 In order to determine if hTERT expression effected HR, the two plasmid 
recombination rates between hTERT/GFP expressing, GFP alone expressing, and normal 
non-transfected cells were compared.  Average results of three experiments on the same 
cell line show no significant differences (p>0.05)  in the rates of HR of the two plasmids 
comparing wild type cells and the same cells expressing GFP or GFP and hTERT (Fig. 
11).  
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Figure 11.  Percentage of colonies from HR of the two truncated plasmids in cells 
           with or without telomerase.  Error bars = standard error for each treatment 
           group.  
 
DISCUSSION 
 
 Among the many proteins involved in NHEJ, Ku 70/80, p53, DNA-PK, and the 
Rad50/Mre11/XRS2 complex have been studied extensively.  Results indicated that 
these proteins as well as others are involved in many different telomeric functions (145).  
Among cell types shown to possess higher rates of HR there is a common aspect in that 
they all express telomerase.  Examples of this are mouse ES cells, regenerating liver 
cells, and Fanconi’s anemia cells (22-24).  To date, there have been no reports on the 
relationship between the expression of telomerase and the rate of HR.  To examine this 
relationship, PFFs virally co-transfected with hTERT and GFP and shown to express a 
functional hTERT, were compared to the same PFF either non-transformed or 
transfected with GFP alone.  The use a plasmid to plasmid recombination system 
allowed for the direct comparison of the rates of HR between cells varying only in 
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telomerase expression.  Unfortunately, no enhancement of HR was seen in the PFFs 
expressing hTERT.  Additionally, hTERT was shown to be active via TRAP assay, 
however, no life extension was seen.  This same cDNA has been shown to increase both 
life span and telomere lengths of human fibroblasts (146,147).  However, studies by Zhu 
et al. (148) showed only life extension and no telomere elongation in previously 
transformed human fibroblasts.  In addition, O’Hare et al. (149) found that 
transformations with hTERT alone was ineffective in immortalizing normal human 
mammary fibroblasts but required the addition of Simian virus 40 (SV40) large T 
antigen.  While there have been no reports of hTERT expression in porcine cell lines, 
ectopic expression of hTERT has been reported in both sheep and bovine cell lines (150-
154).  However, only in sheep has hTERT been successfully expressed in normal 
fibroblasts (150,151).  This hTERT expression was reported to have a dose dependent 
relationship on telomere length.  While any level of expression of hTERT resulted in 
extended life span, only high levels resulted in telomere extension (150).  Interestingly, 
it was found that while TRAP assay results showed only approximately two fold 
differences in the various hTERT positive cell lines, mRNA real time quantitative RT-
PCR (qRT-PCR) and western blot analysis showed nearly 6000 fold differences 
indicating that the TRAP assay, while being able to pick up low levels of enzymatic 
activity, was not able to accurately quantitate the amount of hTERT mRNA and protein 
levels (150).  This same group then attempted cloning with the high expressing hTERT 
positive sheep fibroblasts.  These fibroblasts possessed normal karyotypes and telomere 
lengths and were able to develop to blastocyst stage at similar rates of control normal 
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fibroblasts.  Transferred blastocysts also showed relatively high rates of implantation, 
early fetal development, and organogenesis.  However, no fetuses survived past 40 days 
indicating the hTERT positive cells were not fully competent for nuclear transfer (151).  
Much is still unknown about the action of telomerase and the effects of ectopically 
expressing it in cells and, in the case of our PFFs, it is possible that hTERT is not able to 
activate the machinery needed to allow for extension of life span. 
 While Hata et al. (22) showed naturally hTERT expressing cells exhibited similar 
levels of HR as ES cells, Lindvall et al. (155) showed, by cDNA microarray, that ectopic 
expression of hTERT in normal human fibroblasts resulted in the up regulation of up to 
172 genes and expressed sequence tags (ESTs).  This suggests that hTERT transfection 
results in much more than simply hTERT expression.  What is not know is whether it is 
the hTERT expression itself or the action of one or a multitude of other proteins 
activated by hTERT expression that may play a role in the similar levels of HR seen in 
telomerase expressing somatic cells as compared to ES cells.  Because hTERT 
expression did not alter the life span of the PFFs one can not say if hTERT expression in 
these cells activated any of the other proteins seen in hTERT positive human fibroblasts.  
Therefore, the only conclusion that can be made from these experiments is that the 
expression of a functional hTERT in PFFs does not increase HR efficiencies.  Once a 
porcine telomerase cDNA clone is isolated a more comprehensive study can be done to 
determine if porcine telomerase shows the same phenotypes in PFFs as human 
telomerase shows in human fibroblasts.   
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CHAPTER IV 
EFFECTS OF CELL SYNCHRONY AND DNA NUCLEAR DELIVERY ON THE 
RATES OF HOMOLOGOUS RECOMBINATION IN PORCINE FETAL 
FIBROBLASTS 
 
INTRODUCTION 
 
 When a cell encounters a DSB two unique pathways are available to repair it, 
either NHEJ or HR.  Studies have shown that the NHEJ pathway tends to dominate in 
early S phase of the cell cycle while HR tends to dominate the repair in late S phase (9).  
Because NHEJ relies of the processing of the damaged ends of DNA to find the few 
compatible base pairs needed for ligation of the two ends, it is the most error prone of 
the two repair mechanisms.  HR, on the other hand, requires large areas of homology 
such as sister chromatids, homologous chromosomes, and in the case of targeting, 
targeting constructs, to allow for strand exchange and invasion between the damaged and 
undamaged DNA.  The repair of the DSB is then accomplished when the heteroduplex is 
resolved.   
 It has been known for quite some time that compounds that inhibit replication in 
mammalian cells are potent inducers of sister chromatid exchange, gene amplification, 
and HR (133-137).  DSBs found when replication forks are disrupted are repaired by 
both NHEJ and HR although HR seems to be the dominant repair mechanism 
(138,156,157).  Studies have shown that NHEJ may participate in an early response to 
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repair DSB while HR participates in a late response (138).  Lundin et al. (139) showed 
that the two repair mechanisms occurred in cells arrested with hydroxyurea, which 
completely arrests the replication forks at the beginning of the S phase.  However, when 
cells were arrested with thymidine, which only slows the replication fork, HR was the 
sole mechanism responsible for repairing the damaged DNA.  While they showed that 
thymidine treatment did not cause detectable DSBs, they found that the defective HPRT 
gene was corrected only by HR in cells treated with thymidine.   
 Given this information, we investigated whether synchronization of cells at a 
point in the cell cycle, mid-late S phase, where HR is favored over NHEJ would increase 
the rate of HR.   
 Another method to further increase the rates of HR would be the more efficient 
delivery of the transgene to the nucleus, thus decreasing the time in the cytoplasm where 
it could be degraded.  In addition, rapid delivery to the nucleus allows for longer 
exposure of the transgene to the HR machinery than if cell division and nuclear 
membrane breakdown is required.  Studies of nuclear localization of cytoplasmic 
proteins have shown that they possess a nuclear localization signal (NLS) that interacts 
with specialized cytoplasmic proteins which transport the multimer to the nucleus via a 
nuclear pore complex (NPC) (131).  In addition, Vacik et al. (132) has shown that 
plasmid DNA containing a 366bp sequence from simian virus 40 (SV40) origin of 
replication and early promoter were bound by cytoplasmic transcription factors that 
contain an NLS sequence, and were transported into the nucleus through the NPC.  To 
test whether nuclear delivery of exogenous DNA is beneficially effected by the addition 
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of an NLS bearing protein recognition signal, an 180 base pair sequence from the early 
promoter region of the SV40 promoter of the pCDNA3 vector was added to the two 
truncated puromycin plasmids. 
 The work presented below was undertaken to determine the effects of cell 
synchronicity and efficient nuclear delivery of DNA had on the rates of HR in PFFs.  A 
two plasmid recombination system using two truncated puromycin genes was used and 
the rates of HR in cells treated or untreated with thymidine with or without an NLS 
signal sequence present on the truncated plasmids were compared to normal cells treated 
or untreated with thymidine and transfected with a fully functional puromycin gene.   
 
MATERIAL AND METHODS 
 
Plasmids 
 Two truncated puro vectors were designed.  Primers specific to either the 
pBluescript or puro gene were used to generate the plasmids using a pBS vector 
containing a pgk, puro, and bovine growth hormone polyA sequences for the PCR 
template (Table 1). 
PCR conditions for the 3’ ∆ puro plasmid were initial denaturing at 94ºC for 2 
minutes, 30 cycles of denaturing at 94ºC for 15 seconds, annealing at 62ºC for 30 
seconds, and elongation at 69ºC for 2 minutes followed by a final elongation at 69ºC for 
7 minutes.  The same conditions were used for the 5’ ∆ puro plasmid with the exception 
of the annealing temperature changed to 58ºC.  One ul of Expand High Fidelity 
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polymerase mix, 20mM of each dNTP, and 1.5mM magnesium chloride was used.  The 
resulting fragments were then cloned into a pCR2.1 vector. 
 The 3’ ∆ puro is a plasmid containing only the pgk promoter and a 3’ end 
truncated puromycin acetyltransferase gene and lacks the poly A signal.  The 5’ ∆ puro 
is a plasmid containing a 5’ truncated puromycin gene and the poly A signal but lacks 
the pgk promoter.  Both plasmids share approximately 580bp of homology in the 
puromycin gene.  Neither plasmid is able to elicit puromycin resistance when transfected 
alone into a cell.  However, when both plasmids are introduced into a cell, HR occurs via 
their shared homology and a fully functional puromycin resistant gene is formed (Fig. 6).  
Cells that have undergone a successful recombination event will be able to survive in the 
presence of puromycin.  The rates of recombination, therefore, can be calculated by the 
number of puromycin resistant colonies that arise after selection.   
The early promoter region of the SV40 promoter of the pCDNA3 vector 
(Invitrogen) was amplified using the following primers with FseI adapters at the 5’ end 
(Table 4).  The resulting 180bp PCR fragment was cloned into pCR2.1.  This plasmid 
was then cut with FseI and cloned into the truncated plasmids via a synthetic FseI 
containing linker. 
 
 
Table 4.  PCR primers utilized for generating the NLS sequence 
 
Primer name             Sequence (FseI site) 
 
Early SV40 forward primer  GGCCGGCCGTGGAATGTGTGTCAGTTAG 
 
Early SV40 reverse primer  GGCCGGCCATGGTTGCTGACTAATTGAG 
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Fibroblast Cell Culture andTtransfections 
 Purebred Duroc gilts on days 35 or 36 of pregnancy were hysterectomized and 
the fetuses removed.  The head and viscera were removed from the fetus and the 
remaining tissue was minced with a sterile razor blade.  The tissue was added to 10ml of 
0.05% trypsin supplemented with 0.9mM potassium chloride, 0.9mM dextrose, 0.7mM 
sodium bicarbonate, 0.1mM EDTA, and 20mM sodium chloride.  The tissue/trypsin 
solution was shaken at 37ºC for 15 minutes a total of three times.  After incubation, the 
supernatant was collected, pooled, and pelleted and expanded as described previously.  
The fibroblasts were then trysinized and frozen in 50% FBS, 40% media, and 10% 
DMSO for long time storage and future use.    
Fibroblast cells were re-established from freezing and grown in the (antibiotic 
free) media described above.  The cells were expanded until appropriate numbers were 
obtained.  At the time of electroporation, cells were trypsinized, counted, and aliquotted 
to 10x106 cells per treatment.  Cells were pelleted and resuspended in 0.8ml of cold F10 
Nutrient Mixture (HAM) and placed in a 4millimeter gap electroporation cuvette.  DNA 
was delivered into the cells via electroporation (450 volts, 1 millisecond, 4 pulses). 
In all experiments, 5nM of the linearized 3’ truncated and of the circular 5’ 
truncated plasmid was used.  For the thymidine experiment, 24 hours prior to 
electroporation, 2mM of thymidine was added to the cells at 50-70% confluency.  After 
each electroporation, cells were plated 1-2x106 cells per 10cm tissue culture plate and 
allowed to recover and attach overnight.  Puromycin at the concentration of 2ug/ml was 
added to all plates approximately 24 hours after electroporation and the cells were grown 
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under selection until puromycin resistant colonies were visualized.   Plates were washed 
with phosphate buffered saline and incubated in a 1:1 ratio of methanol:acetone at -20ºC 
for 20 minutes, air dried, stained with trypan blue, and the colonies counted. 
 
Flow Cytochemistry 
 To determine what percentage of cells were arrested in the S phase of the cell 
cycle, propidium iodide staining was performed following manufacture guidelines 
(DNAcon3-ConsulT.S.).  Cells were analyzed on a FACSCalibur (Becton-Dickinson) 
flow cytometer, equipped with a 15mW air-cooled argon laser, using CellQuest (Becton 
Dickinson) acquisition software.  Propidium iodide fluorescence was collected through a 
585/42-nm bandpass filter and list mode data were acquired on a minimum of 20,000 
single cells defined by a dot plot of PI-width versus PI area.  Data analysis was 
performed in ModFit LT (Verify Software House) using PI-width versus PI area to 
exclude cell aggregates.  
 
Data Representation and Statistical Analysis 
 Data sets were transformed, when needed, to aid in acquiring normal distribution 
of values.  Averages of six replications were subjected to ANOVA to determine 
differences between the means of the different treatments.  If a difference was found, 
Fisher’s Least Significant Difference analysis, using SPSS software, was performed to  
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determine which treatments were significantly different at the p< 0.05 level.  Results are 
represented in average colony number of treatment groups (2 plasmids) divided by the 
average colony number of the positive control (single, fully functional puromycin 
resistance plasmid) multiplied by 100.  This value represents the percentage of colonies 
that are the result of homologous recombination.  The charts shown are the frequency of 
HR events per treatment as compared to the control.   
 
RESULTS 
 
Effects of Cell Synchrony on the Rates of HR 
 To study the effect of cell cycle on the rates of HR, cells were synchronized in 
late S phase by overnight incubation in 2mM thymidine.  Propidium iodide staining and 
FACS was used to determine what stage of the cell cycle the cells were in prior to, 
during, and after thymidine treatment.  As shown in Table 5, there was a five-fold 
increase in the percentage of cells in S phase after 24 hour incubation with thymidine.  
Following removal of thymidine the cells quickly recuperated and continued normally 
through the cell cycle.   
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Table 5.  Cell cycle summary 
 
  Treatment   %in S phase   %earlyS  %midS   %lateS 
 
Control              11.9       6.5        2.6        2.8 
12hrs with Thymidine             53       40      10.6        2.3 
24hrs with Thymidine             66       22.5      33.4      10.4 
12hrs after remove 
Thymidine (normal 
Media)                  35        7.3        2.7             25.4 
24hrs after Thymidine            31.1       6.4        1.5       23.3 
36hrs after Thymidine            22        4.7        2.6       14.7 
 
Percentage of cells in the given stages of the cell cycle during various time points before, during, and after 
thymidine treatment of normal porcine fetal fibroblasts 
 
 
Growth Rates of PFFs Transfected with Plasmids with and without an NLS Signal 
 An interesting result was found when cells were transformed with the two 
truncated plasmids containing the NLS recognition sequence.  When compared to the 
same cells transformed with the same plasmids without the NLS the NLS containing 
cells tended to be more robust.  In addition, NLS cell colonies tended to be composed of 
more cells than that of non-NLS colonies.  As summarized in Table 6 and Figure 12 
totals from thirteen electroporations showed approximately two times more colonies in 
cells transfected with NLS containing plasmids.  While there were both small and large 
colonies in each group, overall the colonies were healthier in the NLS cells. 
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Table 6.  Summary from thirteen electroporations of colony number of NLS plasmid 
     cells versus non-NLS plasmid cells 
  
   Average Colony # Per Million  NLS Divided By  
          Cells Electroporated     Non-NLS Colony Number 
             + Standard Error 
 
NLS Cells            5.3+1.3     1.9 
 
Non-NLS Cells     2.8+1.0 
 
 
 
 
 
NLS Plasmid Cell Colony Non-NLS Plasmid Cell Colony
NLS Plasmid Cell Colony Non-NLS Plasmid Cell Colony
 
Figure 12.  Representative pictures of NLS plasmid containing cells and Non-NLS 
           plasmid containing cells. 
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Effects of Nuclear DNA Delivery on the Rates of HR and NHEJ 
 To determine what the effect of faster delivery of the transgene to the nucleus 
would have on HR, an NLS-bearing-protein recognition signal was added to the two 
plasmid recombination system.  Additionally, the interaction between cell synchrony and 
the use of NLS was tested.  The average of six experiments using day 35 and 36 old fetal 
fibroblast cell lines show significant differences (p<0.05) in the percentage of HR:  the 
control plasmids (truncated plasmids with no NLS) with and without thymidine 
treatment, the control plasmids without thymidine and the NLS containing plasmids with 
thymidine, the control plasmids with thymidine and the NLS containing plasmids 
without thymidine, and the NLS plasmids with and without thymidine (Fig. 13). 
 
  
Figure 13.  Percentage of colonies resulting from HR of the two truncated plasmids 
           either with or without the NLS binding sequence and with or without 
           thymidine.  Error bar = standard error of each treatment group.  (p<0.05) 
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DISCUSSION 
 
 An alternative method to enhance HR would be to have the majority of the cells 
synchronized at a point in the cell cycle, mid-late S phase, where HR is favored over 
NHEJ.  Excess thymidine in culture has been shown to inhibit the formation of dCTP, an 
essential precursor to DNA, and therefore dramatically slow the replication fork at the 
latter part of the S phase of the cell cycle (158).  Studies by Lundin et al. (139) indicate 
that after thymidine incubation, correction of the HPRT gene in Chinese hamster cell 
lines was exclusively the result of HR and not NHEJ.  However, a direct comparison of 
HR rates between normal and thymidine blocked cells has not been reported.  Our results 
show a significant increase in the rates of HR between all plasmids involving thymidine 
incubation as compared to the same plasmids without thymidine.  This increase in HR is 
likely due to an increase in Rad51 and other HR molecules present in the cells during 
late S phase and as a result of thymidine treatment.  This theory is further supported by 
the work of Lundin et al. (139) who found a 24-fold increase in HPRT+ recombinants 
(presumably due to HR) and an increase in Rad51 foci in cells treated with thymidine. 
 In addition to having cells in the proper stage of the cell cycle, more efficient 
delivery of the transgene to the nucleus should have a positive effect on the rates of HR.  
Decreased time in the cytoplasm where the exogenous DNA could be degraded and 
rapid delivery to the nucleus allowing for longer exposure of the transgene to the HR 
machinery would both contribute to the higher rates.  Vacik et al. (132) have shown that 
plasmid DNA containing a 366bp sequence from SV40 origin of replication and early 
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promoter were bound by cytoplasmic transcription factors that contain an NLS sequence, 
and were transported into the nucleus through the NPC.  The 180 bp sequence containing 
a 72bp tandem repeat found in the early SV40 promoter was inserted into both of the 
truncated plasmids.  Comparison of these plasmids to plasmids without the added 
sequence showed an increase in the rate of HR.   
 Results indicate an additive effect of both thymidine synchronization and the 
addition of an NLS-bearing-protein binding site on the rates of HR.  The further 
enhancement of HR by the NLS can be seen by the slight non-significant increase in HR 
with the NLS bearing plasmids with thymidine as compared to the control plasmids with 
thymidine.  In addition, separate experiments comparing only NLS and non-NLS 
plasmids showed a two fold increase in colony numbers from cells containing the NLS 
plasmid.   
 Traditional targeting strategies include transfecting asynchronous cell population 
(20% to 30% of cells in S phase at any given time).  Non-S phase transfected cells must 
go through the cell cycle to re-enter S phase and during this time the transgene is in the 
presence of enzymes present in the cytoplasm.  Synchronizing the cells with thymidine 
(greater than 60% of cells in S phase) allows for a much greater percentage of cells 
ready for HR to occur.  The addition of the NLS signal on the plasmids may further 
enhance the rates of HR by transporting the transgene into the protective environment of 
the nucleus faster where HR can take place. 
 Recombination can take place between three types of substrates:  extra-, intra-, 
and inter-chromosomally (for reviews see 84,159).  Extra-chromosomal recombination 
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involves two DNA sequences neither of which are associated with chromosomes (i.e. 
two independent plasmids).  Intra-chromosomal recombination involves the 
recombination of two sequences located on the same DNA molecule (i.e. tandem 
plasmid of two sequences or the two sequences on the same chromosome).  Inter-
chromosomal recombination is the recombination of two sequences on two separate 
chromosomes or between a chromosome and a targeting plasmid.  Chromosomal DNA is 
bound by histones and other regulatory proteins as well as having areas of 
heterochromatin, all of which can hinder its accessibility to HR and NHEJ molecules.  
Extra-chromosomal sequences on the other hand are not impeded by these obstacles.  
Because of this, some reports have suggested that results from plasmid to plasmid assay 
experiments may not necessarily reflect what would occur in normal inter-chromosomal 
recombination (18,84,159-161). 
 Extra chromosomal recombination (ECR) in mammalian cells has been used to 
study recombination mechanisms for over 20 years (for review 159).  This method has 
been chosen mainly due to the ability to obtain results rapidly and the ease of which to 
manipulate the systems.  One of the most used protocols involves the use of two non-
functional selectable markers (usually a neomycin resistant gene) transfected either in 
two individual plasmids or in tandem on a single plasmid.  Selection media is added 24 
hours after transfection and colonies of resistant cells are visible approximately two 
weeks later.  Recombination frequency is calculated by dividing the number of resistant 
cells by the number of colonies arising from a wild type, functional marker transfection.  
Because selection occurs over a two week period, incorporation of the functional 
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selectable marker must occur.  ECR frequencies have been reported in the range of 1-
20% (159,162-167) and the frequency of ECR involving integration has been shown to 
be equal to or greater than those obtained from systems that do not involve integration 
(168).  Based on observations that ECR correction and integration occurred 10 times 
more frequently than integration of the wild type marker, Wong and Capecchi (168) 
have suggested that ECR is coupled with the subsequent integration of the recombined 
molecule.  If the two events are indeed linked then the use of this system to infer on 
other types of recombination may lead to an over-estimation of HR frequency.  In 
addition, there have been variable reports on when in the cell cycle ECR takes place 
(159,162,169,170), the extent of homology between the two sequences necessary for 
efficient HR (159,167,171,172), and what recombination mechanism is responsible for 
ECR (for review see 159).  The only safe conclusion to be made in this field is that ECR 
in mammalian cells involves a multitude of pathways and varies from one experiment to 
another thus making a definitive conclusion difficult.  However, due to the difficulties in 
studying HR in normal mammalian cells using traditional targeting vectors the use of 
ECR is the most practical way of studying the process.     
 Until the exact mechanisms of HR in somatic cells is elucidated or methods are 
developed that can extend the life span while retaining the cells ability to be efficiently 
cloned, any protocol that can increase the efficiency of HR is useful.  Because we used a 
plasmid to plasmid recombination system in this study the increases in HR may not 
reflect actual HR rates in somatic cells between a chromosomal gene and an extra-
chromosomal transgene but the trends should follow that seen in our system.  Due to the 
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current inefficiencies of targeting livestock somatic cells, all labs have relied on the 
promoter trap for enrichment.  With the development of better protocols it could now be 
possible to target non-expressing genes thus opening a vast area of research previously 
inaccessible until now. 
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CHAPTER V 
EFFECTS OF ENHANCERS ON TARGETING OF THE ALPHA 1,3 
GALACTOSYLTRANSFERASE (GT) GENE 
 
INTRODUCTION 
 
 The GT gene product is an enzyme responsible for the addition of a galactose-
α1,3-galactose carbohydrate epitope onto the cell surface (173).  The GT gene has been 
inactivated through several mutations in humans, apes, and old world monkeys.  In 
addition, through continued exposure to gastrointestinal bacteria that express similar 
carbohydrate antigens, humans produce large amounts of anti-Gal antibodies (estimated 
to be as much as 1% of the total circulating Ig) (174,175).  Because of the presence of 
these antigens on pig cells, and the presence of the naturally occurring antibodies in 
humans, the introduction of human blood to a pig organ quickly results in a hyperacute 
immune response (HAR) (173,176-178).  Many non-transgenic and dominant 
negative/over-expression transgenic strategies have been attempted to by-pass human 
HAR to pig organs such as the temporary depletion of the anti-Gal antibodies before 
transplantation, the treatment of pig organs with α-galactosidase to remove the surface 
epitopes, the over expression of competing transferases to lessen the levels of GT 
expression, and the expression of human complement inhibitors such as human decay-
acceleration factor and human CD59 (173,179-181).  However, none of these strategies 
worked in eliminating all of the epitope expression and the residual α-1,3 Gal epitopes 
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were sufficient to activate the HAR.  Complete removal of the epitopes through the 
complete inactivation of the GT gene via homologous recombination should therefore 
cause a complete blockage of the HAR.  Human blood perfusion studies performed on 
the GT double knockout mouse has shown substantially less antibody binding resulting 
in a significant decrease in complement activation and HAR (182).  Three groups (71-
73) have successfully inactivated one copy of the pig GT gene and one of these groups 
recently succeeded in isolating and cloning GT double knockout pigs (75).  However, no 
studies involving human blood perfusion have been reported using any of these animal’s 
tissues.  
 There are basically three types of HR:  single strand annealing (SSA), gene 
conversion (GC), and break-induced replication (BIR) (183).  SSA is the simplest of the 
mechanisms and involves the resection (5’ to 3’) and exposure of complementary 
regions of homology sequences originally flanking the DSB.  This process is prone to 
creating deletions and will occur with as little as 30bp of homology although it is more 
efficient with 200-400bp (184).  Gene conversion is in competition with SSA in that GC 
uses the two resected ends to invade and copy the sequences from a homologous 
template located on a sister chromatid, homologous chromosome, or an ectopic location 
(i.e. targeting construct).  Because of this, GC is considered the least error prone of the 
HR mechanisms.  The third type of HR is break induced recombination.  BIR occurs 
when only one resected end of the DSB participates in the exchange with homologous 
sequences.  Elongation of this single invading strand off of its homologous sequence will 
continue until it either meets the end of the chromosome or until it encounters a 
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converging replication fork.  Only GC and BIR involve invasion and elongation and 
therefore involve the action of Rad51 while SSA is Rad51 independent. 
 Due to the availability of the three types of recombination mentioned above and 
because of the possible discrepancy between extra- and inter- chromosomal 
recombination discussed in the previous chapter, testing of some of the enhancers 
presented previously were tested on an actual locus, the α-1,3-galactosyltransferase (GT) 
gene, using several different types of targeting vectors.  From the previous results we 
determined that mutated p53, thymidine synchronization, and the addition of an NLS-
bearing protein recognition signal positively affected the rate of plasmid to plasmid 
recombination.  However, because of the tendency of cells with mutant p53 to become 
aneuploid there was concern in using this type of enhancement in cells destined to be 
cloned.  While the use of both thymidine synchronization and NLS seem the best choices 
for enhancing HR in PFFs, most of the enhancers discussed in the previous chapters 
were examined to some extent. 
 
MATERIAL AND METHODS 
 
Generation of GT Targeting Constructs 
 Using the porcine α1,3 galactosyltransferase cDNA sequence obtained from the 
GenBank (NCBI) database, the primers were designed (Table 7).  Long range PCR (LR-
PCR) on porcine genomic DNA using primer set GT1A resulted in a six kilobase 
fragment and primer set GT1B resulted in a seven kilobase fragment (Fig. 14).  The two 
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fragments were then inserted into pCR2.1 vectors using the TA cloning technique 
(Invitrogen).  The two plasmids were sequenced and confirmed via Blast search 
(GenBank) as containing porcine GT exon coding sequences (Fig. 14).   
 
 
Table 7.  PCR primers utilized for generating the two GT constructs 
 
Primer name      Sequence 
 
GT1A forward primer   ATGGAAGGCTCCAGTGGTATGG 
 
GT1A reverse primer   GACCTGATCCACGTCCATGCAG 
 
GT1B forward primer   AAAGAAGACAACAGAGGAGAGCTTCCGC 
 
GT1B reverse primer   GTGCCTTCCCATACCACTGGAGCC 
 
GT2 forward primer    AGAGGTCGTGACCATAACCAGAT 
 
GT2 reverse primer    AGCCCATCGTGCTGAACATCAAGTC 
 
 
 
 
 
 
50 bp 
Figure 14.  Schematic of the DNA amplified by long range PCR using primers specific 
         to GT. 
 
 
 Using these two plasmids as the basis for the two “arms” of the final construct, 
various restriction enzymes were used to obtain a five kilobase fragment from the 
Exon 7 Exon 8
170 bp 225 bp
Exon 9
6 kb 7 kb 
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original seven kilobase fragment for insertion into pBS.  Using this plasmid, the pgk, 
puromycin acetyltransferase, poly A gene (minus either the promoter or poly A part of 
the gene) was inserted.  Inserting a 4kb fragment from the original 6kb PCR fragment 
downstream from the puromycin-resistant gene completed the left arm of the targeting 
construct (Fig. 15).   
 
 
 
 
Ex8 Puro Gene Ex8
5kb 4kb 1kb
Figure 15.  Schematic of the first completed targeting construct used to target the GT 
          gene in porcine fibroblasts. 
 
 
 An additional plasmid similar to the targeting construct used by Dai et al. (72) to 
target the GT locus was constructed.  LR-PCR was performed on porcine genomic DNA 
using the GT2 forward and reverse primers (Table 7).  The resulting 7.4kb fragment 
included most of exon 8 through exon 9 of the GT gene.  A 1.8kb internal ribosome 
entry site (IRES), neomycin poly A fragment was then inserted into exon 9 to disrupt 
gene function and allow for the selection of targeted events (Fig. 16).   
 
 
 
 
 
Figure 16.  Schematic of the second completed targeting construct used to target the GT 
        gene in porcine fibroblasts. 
Intron 8 
5.5kb 1.8kb 1.9kb 
Ex9 Exon 9 Ex8 NLSNEO pAIRES
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The early promoter region of the SV40 promoter of the pCDNA3 vector 
(Invitrogen) was amplified using primers with FseI adapters at the 5’ end (Table 4).  The 
resulting 180bp PCR fragment was cloned into pCR2.1.  This plasmid was then cut with 
FseI and cloned into both GT plasmids via a synthetic FseI containing linker. 
 
Isolation of Fibroblast Cells 
 Purebred Duroc gilts on days 35, 36, or 57 of pregnancy were hysterectomized 
and the fetuses removed.  For day 35 and 36 fetuses, the head and viscera were removed 
and the remaining tissue was minced with a sterile razor blade while with the day 57 
fetuses, the skin was removed from the hind leg and the muscle was minced.  The tissue 
was added to 10ml of 0.05% trypsin supplemented with 0.9mM potassium chloride, 
0.9mM dextrose, 0.7mM sodium bicarbonate, 0.1mM EDTA, and 20mM sodium 
chloride.  The tissue/trypsin solution was shaken at 37ºC for 15 minutes a total of three 
times.  After incubation, the supernatant was collected, pooled, and pelleted.  The cell 
pellet was resuspended in DMEM/F12 media supplemented with 10%FBS and 5%CS, 
30mM sodium bicarbonate, 0.5mM pyruvic acid, and 2mM N-acetyl-L-cysteine.  In 
addition, 100U penicillin, 100ug, and 250ng amphotericin were added to inhibit microbe 
growth.  The  fibroblast cells were placed in the appropriate number of 10cm tissue 
culture plates and placed in a 5% CO2 incubator at 39ºC and allowed to attach and grow 
to confluency and then passed (1:2 or 3).  The cells were then trysinized and frozen in 
50% FBS, 40% media, and 10% DMSO.    
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Electroporation 
Cells were re-established from freezing and grown in the (antibiotic free) 
medium described above.  The cells were expanded until appropriate numbers were 
obtained.  At the time of electroporation, cells were trysinized, counted, and aliquotted to 
10x106 cells per treatment.  Cells were pelleted and resuspended in 0.8ml of cold F10 
Nutrient Mixture (HAM) and placed in a 4millimeter gap electroporation cuvette.  DNA 
was delivered into the cells via electroporation (450 volts, 1 millisecond, 4 pulses).  
Approximately 10 x 106 cells were electroporated with 5nm of either the linear or 
circular construct with or without 5nM of the enhancers (i.e. truncated Mre11, Anti-Ku 
RNA aptamer, mutated p53, or the addition of the NLS signal to the targeting plasmid).  
Another 2 x 106 cells were electroporated with either 5nM of the pgk puro pA DNA 
control or with no DNA as a negative control.  For the thymidine experiments, 24 hours 
prior to electroporation, 2mM of thymidine was added to the cells at 50-70% confluency.  
After electroporation the cells were given time to recover and then put on selection when 
70% confluency was reached.  Selection with 1.5 to 2.0 ug/ml of puromycin was carried 
out for about ten days or until a visible, compact colony had grown.  Individual colonies 
were then passed via cloning rings into a well of a 96-well plate.  After several rounds of 
passages up to at least two wells in a 24 well plate one half of the cells were frozen in 
liquid nitrogen in a 50% serum, 10% DMSO media solution while the second half was 
used for DNA or RNA extraction following standard protocol.   
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Lipofection 
 As an alternative to electroporation, lipofection, was also studied.  Fibroblasts 
were transfected using LipofectAMINE TM 2000 Reagent (Life Technologies).  
Following the suggested protocol, the appropriate amount of DNA (either linear or 
circular construct with the appropriate controls) plus 5nM of enhancer molecules (i.e. 
truncated Mre11, Anti-Ku RNA aptamer, mutated p53) were added to the lipofection 
solution and put on the fibroblast overnight.  After sufficient time for recovery, the cells 
were put on selection (1.5 to 2.0 ug/ml puromycin) for about 10 days or until a visible, 
compact colony had grown.  The cells were then passed and analyzed as in the 
electroporation protocol.   
 
Diagnostic Testing for Possible Positive Targeting Events 
 The integrity of the extracted DNA and RNA was checked on a 0.8% gel.  
Approximately 50-100 ng of DNA was used in each subsequent PCR.  For GT1, several 
primer pairs were used in the PCR diagnostic procedures.  One half of these primer pairs 
contain one primer to different endogenous areas of the targeted gene and the other 
primer to areas of genomic DNA inside the construct.  The second half of primer pairs 
contains one primer to different endogenous areas of the targeted gene and the other 
primer to the puromycin resistance gene inside the construct (Fig. 17).  Analysis of 
several PCR results by Southern blot using both genomic DNA and puromycin DNA as 
probes was used to determine which puromycin resistant colonies were true targeted 
events.  In addition, in certain experiments, 7.5ug of RNA was used for first strand 
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cDNA synthesis following the Prostar First Strand RT-PCR Kit protocol.  The primers 
used to amplify regions of the targeted cDNA are presented in Table 8 and a schematic 
of these areas on the cDNA is presented in Fig 18. 
 
 
 
 
 
 
 
 
 
Figure 17.  Schematic of primers used for the diagnostic tests on possible positively 
          targeted GT1 colonies.  Like letters represent primer pairs used for LR-
          PCR.  When the same letters are together indicates nested or semi-nested 
          primer sets.  The area of genomic DNA encompassed by the targeting 
          construct is indicated. 
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Table 8.  PCR primers utilized for generating RT-PCR product from possibly GT1 
     targeted colonies 
 
Primer name      Sequence 
 
(A) GT-Exon7 forward primer AAAGAAGACAACAGAGGAGAGCTTCCGC 
 
(B) GT-Exon8 forward primer AAACGCCCAGAGGTCGTGAC 
 
(C) Puro forward primer  CCGAGTACAAGCCCACGG 
 
(D) Puro reverse primer  GCTTGCGGGTCATGCAC 
 
(E) GT-Exon9 reverse primer  GAACTCCTCCAAGTAATGCTCAATG 
 
 
 
 
 
 
 
Figure 18.  Schematic of the priming sites of  the cDNA diagnostic primers.  A,B, and 
        C are forward primers while D and E are reverse primers.  The area of the 
        cDNA encompassed by the construct is indicated. 
 
 
 To determine positive targeting events using the GT2 plasmid the primers listed 
in Table 9 and shown schematically in Fig. 19 were used on genomic DNA isolated from 
G418 resistant colonies.  All colonies that survived transfer, passage, and grew well 
enough to have DNA extracted from them were analyzed by LR-PCR using primer set 
B/D, transferred to membranes, and probed with the IRES probe.  Possible positives 
from this initial screen were re-probed with a neo probe and were also further analyzed 
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by LR-PCR using primer sets A/E and C/F.  Membranes with primer set C/F LR-PCR 
products were then probed with the IRES probe.   
 
 
Table 9.  PCR primers utilized for generating LR-PCR product from possibly GT2 
     targeted colonies 
 
Primer name      Sequence 
 
(A) GT2-Intron7 forward primer1 TGTCCCTCCCCCAGAAGATG 
 
(B) GT2-Intron7 forward primer2 CCTTAGCAAAGCCATCCTGACTC 
 
(C) GT2-Intron7 forward primer3 TTAGCAAAGCCATCCTGACTC 
 
(D) GT2-Exon9 reverse primer AGCCCATCGTGCTGAACATCAAGTC 
 
(E) GT2-Neo reverse primer2  GGATACTTTCTCGGCAGGAGCA 
 
(F) GT2-IRES reverse primer1 GTTGAATACGCTTGAGGAGAGC 
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Southern Blot Analysis 
 PCR products were visualized by electrophoresis through a 0.8% agarose gel in 
1xTAE.  The gel was stained with ethidium bromide to visualize and document the PCR 
product and DNA size ladder.  The gel was soaked for 1 hour in 50mM NaOH and 1.5M 
NaCl to denature the DNA and then transferred to 500mM Tris-HCl (pH 7.4) and 1.5M 
NaCl  for  30 minutes to neutralize before soaking in 20xSSC (3M NaCl, 300mM 
Na3Ci).  DNA was transferred to nitrocellulose by capillary action of 20xSSC through 
filter paper and DNA was cross linked to the membrane by UV exposure for 3 minutes 
and dried at 80ºC for 2 hours.   
 The four probes used, puro probe, IRES probe, neo probe, and GT exon 8 probe, 
were generated as follows.  The puro probe primers listed in Table 10 were used to 
generate a 327bp fragment of the puromycin gene which was then cloned into a pCR2.1 
vector.  The fragment was excised from the plasmid with EcoRI, gel purified and used 
for probing.  The exon 8 probe was generated from an ApaI and EcoRI digest of the 
PCR product of the GT1A primer set (Table 7 and Fig. 14) resulting in a 200bp piece 
that was sub-cloned into pBS.  The fragment was excised from the plasmid using ApaI 
and EcoRI, gel purified, and used for probing.  The IRES probe was generated from 
HindIII digest of the GT2 targeting construct (Fig. 16).  The resulting 348bp fragment 
represented part of the IRES and was sub-cloned into pBS.  The fragment was excised 
form the plasmid with HindIII, gel purified, and used for probing.  The second probe 
used in the GT2 diagnostics was the neo probe.  This probe was generated by BamHI 
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and PvuII digest of the pBSNEOTK plasmid.  The resulting 560bp neomycin gene 
fragment was gel purified and used for probing.   
 
 
Table 10.  PCR primers utilized for generating the puro probe used in Southern blot 
 
Primer name               Sequence 
 
Puro Probe forward primer    CGAGTACAAGCCCACGGTGC 
 
Puro Probe reverse primer    GCCTTCCATCTGTTGCTGCG 
 
 
 
 Radioactive probe (32P-dCTP, Amersham) was random primed using the NEBlot 
Kit (New England Biolabs) according to manufacturer’s recommendations and purified 
through a Sephadex G-50 column.  Blots were hybridized with Rapid Hyb (Amersham) 
and 1 million dpm/ml of hybridization solution at 65ºC for 2 hours.  Hybridization 
solution was removed and the blots were washed at room temperature with either 4xSSC 
with 0.1% SDS for 10 minutes or a series of washes (2xSSC at room temperature, 
0.1xSSC twice at 65ºC) with 0.1% SDS for 15-20 minutes before exposure to 
radiography film.   
 
Cloning 
 Oocytes, obtained from Bomed (Madison, WI), were matured in Earle’s TC199-
Hepes supplemented with 5ug/ml insulin, 10ng/ml EGF, 0.6mM cysteine, 0.2mM 
sodium pyruvate, 25ug/ml FSH, and 10% porcine follicular fluid for 40 hours prior to 
manipulation (all chemicals were purchased from Sigma unless otherwise noted).  
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Following 38-40 hours of maturation, cumulus cells were removed from the oocyte by 
vortexing in 0.1% hyaluronidase in TC199.  Oocytes were then rinsed through three 
drops of manipulation media (salt buffered Ca+ free NCSU-23 containing 5% FCS, 
osmolality 297+3 with pH 7.4).  The manipulation media was made by replacing sodium 
bicarbonate with enough sodium chloride to increase osmolarity to 297+3, and the pH 
was adjusted to 7.4 with 1M sodium hydroxide.  The oocytes were incubated in 
manipulation medium containing 5ug/ml cytochalasin B, and metaphase II oocytes were 
enucleated by removal of the first polar body and metaphase plate utilizing a 25um 
beveled glass pipette.  Absence of the metaphase plate was visualized by exposure to 
ultraviolet florescent light. 
 Reconstruction was conducted in manipulation media.  Porcine fetal fibroblasts 
were seeded in a 4 well plate at 35% confluency and grown until contact inhibited.  The 
cells were trypsinized until the cells started to detach and were then resuspended in salt 
buffered NCSU-23 containing 10% FBS (185).  The cells were placed in a separate drop 
of salt buffered NCSU-23 with 0.8mM CaCl2 2H2O and 10%FBS.  Groups of 15-20 
cells were loaded in the pipette and a single cell was placed in the perivitelline space of 
the oocyte.  Following reconstruction, the oocytes were placed in a 1mm fusion chamber 
and given an alignment pulse of 2 volts alternating current (AC) for 2 seconds followed 
by 2 direct current (DC) pulses of 40 volts for 50 microseconds in 297mM Mannitol, 
0.001mM CaCl2 and 0.05mM MgCl2.  Following fusion, the oocytes were placed in 
bicarbonate buffered NCSU-23, osmolarity 297+3 with 10% FBS for 1 hour prior to 
activation. 
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 Reconstituted oocytes were activated by two DC pulses of 120 volts for 60 
microseconds in 297mM Mannitol, 0.1mM CaCl2, and 0.05mM MgCl2.  Following 
activation the oocytes were placed back in bicarbonate buffered NCSU-23 osmolarity 
297+3 with 10% FBS for 1-3 hours until transfer. 
 All reconstructed oocytes were transferred into naturally cycling gilts on the first 
day of standing estrus.  A mid-ventral laparotomy was performed, the reproductive tract 
was exposed and the reconstructed embryos were transferred into the oviduct at the 
ampullary-isthmus junction.  All experiments were approved by the Institutional 
Agricultural Animal Care and Use Committee of Texas A&M University.  Maintenance 
of pregnancy was aided by the forced ovulation/corpus luteum development using a 
combination of PMSG and hCG.  PMSG (1,250 IU) was injected i.m. on day 11 of the 
estrous cycle (day 0 = first day of standing heat) and 750 IU of hCG was injected i.m. 
three days later (day 14 of the cycle).   
 
RESULTS 
 
Electroporation and Lipofection of the GT1 Targeting Plasmid 
 As summarized in Table 11, over one hundred electroporations using either the 
promoter trap construct (~60) or the polyA trap construct (~41) and approximately 
twelve lipofections using either the promoter trap construct (~5) or the polyA trap 
construct (~7) were performed and the colonies surviving puromycin selection analyzed.   
A total of 131 colonies survived selection and 68 (52%) of these survived passages and 
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grew well enough for DNA and/or RNA isolation.  While there is not enough data to 
determine a statistical difference, there was a marked difference between lipofection and 
electroporation in both the number of colonies and the number of colonies surviving 
passages.  There was a 34 fold increase in the number of circular polyA trap colonies 
and a 9.4 fold increase in linear promoter trap colonies using lipofection instead of 
electroporation for the introduction of the construct into the cell.  Also, 100% of the 
lipofection colonies surviving selection survived the passages while only 37% of the 
electroporated colonies survived.   
 
 
Table 11.  Summary of electroporations and lipofections 
 
Linear/Circular 
Construct 
Electroporation/
Lipofection 
Number 
Of Cells 
Used 
Col. 
Surv. 
Trt. 
Col. 
Surv. 
Pass. 
Col. 
PCR 
Pos. 
Col. 
Enrich 
With 
Anti 
Ku + 
p53 
Enrich 
With 
Anti 
Ku 
Enrich 
With 
p53 
Circular PolyA 
Trap Electroporation 230x106 28 13 13 0 0 0 0 
Circular PolyA 
Trap Lipofection 10x106 4 4 4 0 1 1 1 
Circular Promoter 
Trap Electroporation 80x106 0 0 0 0 0 0 0 
Circular Promoter 
Trap Lipofection 10x106 0 0 0 0 0 0 0 
Linear PolyA Trap Electroporation 175x106 22 13 13 0 1 0 0 
Linear PolyA Trap Lipofection 6x106 0 0 0 0 0 0 0 
Linear Promoter 
Trap Electroporation 520x106 50 11 11 0 0 0 0 
Linear Promoter 
Trap Lipofection 42x106 27 27 27 1* 6 2 1 
* See below 
Summary of electroporations and lipofections performed using the GT1  targeting plasmid either with a 
promoter trap or polyA trap and either linearized or circular constructs.  In some experiments, various 
enhancers  were added and the colonies surviving in this treatment are also presented.  Data presented 
include the total number of cells transfected, the number of colonies surviving the initial selection, the 
number surviving the expansion (passage), the number of colonies analyzed by PCR and those found 
positive for a targeting event, and the number of colonies that resulted from experiments involving the 
addition of the indicated enhancers. 
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 DNA was extracted from all the surviving colonies and a series of primers were 
used for LR-PCR analysis followed, in most cases, by Southern blot analysis of the LR-
PCR products using either a puro probe or an exon 8 probe.  No colony showed 
conclusive results indicating a positive targeting event (Table 12 and Fig. 20).   
 
 
 
 
 
 
 
 
Figure 20.  Schematic of primers used for diagnostic analysis of the genomic DNA 
           using LR PCR on GT1 colonies surviving puromycin selection.  Like 
           letters represent primer pairs used for LR-PCR.  When the same letters are 
           together indicates nested or semi-nested primer sets.  The area of genomic 
           DNA encompassed by the targeting construct is indicated. 
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Table 12.  PCR primers utilized for diagnostic tests  
 
Primer Set Number of  Expected PCR Results            Southern Blot  
   (Type)   colonies  Bands if              Results (Probe) 
    analyzed Targeted 
 
A (hemi-nested)       5         1         No correct size bands            N/A 
 
B (nested)          6         1           No correct size bands    Non-specific binding 
                  (puro) 
 
C (hemi-nested)         0        2          Could not optimize            N/A 
            No correct size bands 
 
D (normal)         15        2          Correct size bands          Non-specific binding
    
E (normal)         16       2           Single band only                        N/A 
 
F (normal)         60       2          Multiple bands some       Non-specific binding 
           Include correct size                    (puro) 
                        Binding only to 
                      lower/endogenous 
                          band (exon8) 
 
G (normal)             42       2        Multiple findings:  Non-specific binding 
                No bands,    (puro) 
            Single band on        Binding only to  
       some electroporations,     lower/endogenous 
         Two bands on some        band (exon8) 
              Lipofections           
 
PCR primers utilized for diagnostic tests on the surviving colonies of the GT1 construct transfections.  
Primer name, number of colonies analyzed, expected LR-PCR results, and actual LR-PCR and Southern 
blot results are given. 
 
 A positive but inconclusive result from a LR-PCR using primer set E on one 
colony from a lipofection using linearized promoter trap GT1 with the addition of the 
anti-Ku RNA aptamer, mentioned in chapter II, was determined promising and was 
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chosen for further analysis.  Total RNA was isolated from this colony and RT-PCR was 
performed using the primers in Table 8.  The ethidium bromide gel of the PCR products 
is shown in Fig. 21.    
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Figure 21.  Ethidium bromide gel showing results from RT-PCR of D883-3 PFF                 
         lipofected with linear GT1 promoter trap DNA and anti-Ku RNA aptamer.  
         Primer set B/D resulted in the expected 620bp fragment, primer set A/D 
         resulted in the expected 670bp fragment, primer set C/D did not result in 
         the expected 590bp fragment.  Primer sets A/E and B/E resulted in the 
         smaller expected fragment (190bp/140bp respectively), but not in the larger 
         expected fragment (780bp/730bp respectively). 
 
 
 Due to the nature of the primers used for RT-PCR, a correctly targeted colony 
would result in a 670bp fragment from primer set, ex7FP to puroRP, and a 620bp 
fragment from the primer set, ex8FP to puroRP.  The non-targeted second allele would 
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not give a PCR result because of the puro binding site of the reverse primer.  Similarly, 
the puro forward and reverse primers should only give a result from the targeted (or 
randomly inserted) gene, however, we did not see a band at the expected size of 590bp.  
The primer sets, ex7FP to ex9RP and ex8FP to ex9RP, should amplify two fragments, 
one from the non-targeted allele (190bp/140bp respectively) and the other from the 
targeted allele (780bp/730bp respectively).  However, only the smaller endogenous band 
was visible after PCR probably due to the preferential amplification of the smaller 
product, a phenomenon common in PCR. 
 Because of the promising results of the presence of a correct size band in both the 
ex7FP to puroRP and ex8FP to puroRP, it was decided to attempt cloning of these cells 
in order to first, determine if it would be possible to clone PFFs that had been grown for 
over 40 days and had undergone strenuous selection and secondly, to obtain enough 
tissue from the cloned piglets to do a genomic Southern blot, a process that is hindered 
in cell culture due to the finite lifespan of the PFFs.  Cloning resulted in the birth of eight 
healthy, normal Duroc piglets and one diminutive Duroc piglet that died three days after 
birth (Fig. 22).  The remaining eight piglets continued to be healthy and developed 
normally until the time of their slaughter four and one half months later.  Genomic DNA 
was isolated from ear and tail samples from all piglets.  However, Southern blot analysis 
using either the exon 8 probe or the puro probe yielded ambiguous results (data not 
shown).  LR-PCR using primers from exon 7 to the 3’ end of exon 8 resulted only in the 
endogenous non-targeted band.  RNA was then isolated and RT-PCR with various 
primers were used to determine if the GT allele was indeed targeted.  Unfortunately, no 
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RT-PCR results showed conclusive proof of gene targeting.  In order to determine 
whether these clones were transgenic, a puro forward and reverse primer was use for 
PCR on genomic DNA from all piglets.  The product was gel purified, cloned into 
pCR2.1 and sequenced.  Sequence analysis showed the existence of a normal puromycin 
gene fragment expected given the primers used.  This proves that while the GT allele 
may not have been targeted, viable transgenic piglets were produced. 
 
(A) 
 
(B) 
 
Figure 22.  Pictures of the litter of transgenic clones born in February 2002.  (A)  All 
         nine piglets nursing shortly after birth.  The diminutive baby is the piglet in 
         the middle, the fifth on from either end.  (B)  Closer picture of some of the 
         normal sized piglets. 
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 In addition to the above work with the GT1, another set of experiments 
incorporating the findings from the enhancer projects mentioned earlier was undertaken.  
An NLS-bearing protein recognition signal was added to the GT1 in a manner similar to 
that of the truncated puromycin plasmids and electroporations were performed either 
with or without thymidine.  A summary of the results from these experiments is in Table 
13.  Unfortunately, no puromycin resistant colonies resulted from any of these 
electroporations even when the puromycin selection concentration was lowered.  In 
addition, it was seen in this and all other experiments involving thymidine that the cells 
exposed to thymidine for 24 hours tended to be less robust and did not survive 
electroporation as well as those cells not treated with thymidine.   
 
 
Table 13.  Summary of GT1/NLS with or without Thymidine 
 
Construct Electroporated  Number of Cells  Colonies Surviving 
       Electroporated           Selection 
 
GT1/NLS without Thymidine        26 x 106            0 colonies 
 
GT1/NLS with Thymidine           247.7 x 106            0 colonies 
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 During the course of the above work, three groups reported successful targeting 
of the α1,3 galactosyltransferase gene (71-73).  It was decided to re-develop a construct 
similar to the one used by Dai et al. (72) (Fig. 16).  However, our construct differed in 
two ways, first it contained most of exon 8 and the 5’ end of intron 8 not present in the 
construct used by Dai et al. and second, we inserted a concatamer of at least three NLS 
recognition signals at the 3’ end of the construct outside the area of homology to GT.  
Our first goal was to compare the HR efficiencies between the GT1 and GT2 constructs 
(both containing NLS) therefore nine electroporations of 10x106 cells each were 
performed with the GT2 construct in the absence of thymidine and a smaller experiment 
of two electroporations (5x106 and 2x106 cells) was performed with GT2 and thymidine.  
A summary of results from the GT2 experiments is in Table 14.   
 
 
Table 14.  Summary of GT2/NLS with or without Thymidine 
 
Construct Electroporated  Number of Cells  Colonies Surviving 
       Electroporated           Selection 
 
GT2/NLS without Thymidine        90 x 106            672 colonies 
 
GT2/NLS with Thymidine                  7 x 106                2 colonies 
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 A total of 674 (~7 colonies per million cells electroporated) colonies were 
transferred and grown.  Of these 356 (~53%) colonies grew well enough to either freeze 
or extract DNA or both.  LR-PCR was performed on all 356 colonies using primer set 
B/D from Table 9 of which 310 (~87%) gave a PCR result (Fig. 23), however, no 
colonies gave the expected double band pattern at 7.9kb and 9.6kb representing both the 
non-targeted and targeted alleles.   
 
 
Figure 23.  Representative ethidium bromide gel of LR-PCR products using primer set 
  B/D from Table 9.  The expected products are bands at 7.9kb (endogenous 
  allele) and at 9.6kb (targeted allele).  The lanes marked represent two   
  potential positive colonies. The arrows show the position where the non-
  targeted and targeted bands should be. 
 
 
 
 All LR-PCR reactions were separated by electrophoresis, transferred to a 
membrane, and probed with the IRES probe.  From this, twelve “possible positive” 
clones were identified having a positive band located near the expected size of the 
targeted LR-PCR product (9.6kb).  To further verify these possible positives, their 
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membranes were stripped and re-probed with the neo probe (Figs. 24 and 25).  The 
results of these two Southern blots showed three colonies that gave a promising band at 
the expected targeted allele size but also gave unexplainable, additional bands.  In 
addition, DNA from the twelve colonies was amplified using the primer sets, A/E and 
C/F from Table 9.  However, no bands were visible using these primers.  As a further 
test, the PCR products from the C/F reaction were transferred to a membrane and probed 
with the IRES probe, but no positive signals were found. 
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Figure 24.   Radiograph of Figure 23 LR-PCR products using primer set B/D from 
 Table 9 probed with the IRES probe.  The lanes marked represent the 
 potential positive colonies.  The arrows represent the area where the 
 endogenous (7.4kb) and targeted (9.4kb) LR-PCR products should be.  
 Only the targeted band should react with the IRES probe used.   
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Figure 25.   Radiograph of Figure 23 LR-PCR products using primer set B/D from 
 Table 9 probed with the neo probe.  The lanes marked represent the 
 potential positive colonies.  The arrows represent the area where the 
 endogenous (7.4kb) and targeted (9.4kb) LR-PCR products should be.  
 Only the targeted band should react with the neo probe used.   
 
 
 
DISCUSSION 
 
 The three groups (71-73) that have reported successful targeting of the GT gene 
utilized different transfection, construct, or selection mechanisms resulting in outcomes 
of efficiency that are difficult to compare.  Harrison et al. (73) attempted targeting first 
with a GFP fusion protein directly upstream of a pgk puromycin gene which was 
inserted into and disrupted exon 9.  They chose a lipofection based method to introduce 
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the construct and passed the cells to lower density plates 24 hours after transfection.  Of 
the 1400 puro resistant colonies, zero were found to produce enough GFP product to be 
measured by FACS and concluded that perhaps the GT promoter was too weak to drive 
sufficient amounts of GFP.  Using LR-PCR one putative positive was identified giving a 
0.07% targeting efficiency (1 colony divided by 1400 colonies multiplied by 100).  Their 
second attempt at targeting utilized a neo fusion promoter trap construct (without an 
IRES) inserted/disrupting exon 4.  They again chose lipofection and passed cells to 
lower density 24 hours after transfection.  In this experiment, however, they divided the 
cells into two groups, low O2 and ambient O2 atmosphere.  The low O2 group seemed to 
do better in that of the 225 G418 resistant colonies found, six were positive targeting 
events giving a 2.7% targeting efficiency.  The ambient O2 group resulted in 170 
colonies of which three were positive giving a 1.8% targeting rate.  Overall, 395 colonies 
were analyzed and nine were found to be positive giving an overall targeting rate of 
2.3%. 
 Lai et al. (71), while basically interrupting exon 9 in the same way as Dai et al. 
(72) (an IRES fused to a promoterless neomycin resistant gene), used a construct which 
was considerably longer and had more homology to the GT gene (21kb versus 8.6kb).  
They chose to transfect only the GT DNA minus the vector backbone into the cells by 
electroporation and passage to lower density after 48 hours.  They also chose to use a 
cell line from a highly inbred strain of miniature pigs and not the out-bred breeds of pigs 
used for all other GT work.  Given the data reported, 159 G418 resistant colonies were 
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analyzed and eight were determined positive giving a targeting efficiency of 5%, the 
highest of all groups. 
 Dai et al. (72) used the IRES fused to a promoterless neomycin resistant gene 
inserted/disrupting exon 9.  Electroporation of this construct with the vector backbone 
followed by passage to lower density 48 hours later resulted in 1105 G418 resistant 
colonies of which 30 probable (17 proven) colonies were targeted.  This gave a 2.7% 
targeting efficiency.      
 In the work presented here no successful targeting events were found.  Using the 
GT1 vector without the NLS signal resulted in 37 colonies analyzed from 
electroporation experiments and 31 colonies analyzed from lipofection experiments.  
The GT1-NLS construct gave no colonies after electroporation either with or without 
thymidine.  Electroporation of the GT2 construct resulted in the analysis of 356 colonies.  
In addition to determining targeting efficiency, it is important to normalize the data to 
the number of cells transfected and, by extrapolation, how many colonies would result 
per million cells transfected.  A summary of all the experiments mentioned above is 
given in Table 15.   
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Table 15.  Summary of published GT targeting statistics 
 
Group          # Cells              # Colonies       # Colonies Per       # Positive        % 
Targeting 
       Transfected            Survive To      Million       Colonies           Efficiency 
                 Analysis          Transfected 
 
Harrison     11.5x106     1400           122          1                    0.07% 
(Puro)* 
 
Harrison      0.252x106     395       1567          9                      2.3% 
(Neo)* 
 
Lai**       80x106      159            2          8          5% 
 
Dai**       14x106    1105          80        30             2.7% 
 
GT1 EP     1005x106        37        0.04          0   0% 
 
GT1 Lipo   68x106        31        0.5           0   0% 
 
GT1-NLS   273x106          0         0           0   0% 
 
GT2-NLS   97x106      356         4           0   0% 
 
* Passage of cells 24 hours after transfection 
** Passage of cells 48 hours after transfection 
 
 
 Because of the differences between experiments, the only realistic comparison is 
between Dai et al. and the GT2-NLS.  While it is sometimes unwise to compare 
experiments from different laboratories and because Dai passed their cells after 
transfection, therefore possibly skewing the numbers, one can make some tentative 
comparisons between the two sets of experiments.  There was a 20-fold decrease in the 
number of colonies per million cells transfected when an NLS was present on the 
construct.  The presence of an NLS could be responsible for lowering the amounts of 
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random integrations and therefore lessening the number of colonies surviving selection.  
It should also, theoretically, enrich for HR events however we were unable to identify 
any positively targeted colonies.  Given the targeting efficiency of 2.7% found by Dai, 
our experiment should have resulted in 8 of the 356 colonies analyzed being positively 
targeted.  Taking into account the passage of the cells 48 hours (and thus two cell 
cycles/replications of the cells) before selection was added, we could assume at least one 
if not two doublings of the cell population giving a 2 to 4 times increase in the targeting 
efficiency found by Dai et al. (72).  This would lower the value of the expected colonies 
to be found in the 356 colonies isolated from the GT2-NLS experiment to 2 to 4 
colonies.  This value reflects what would be expected without the added enrichment of 
the NLS.  We would expect a higher number of positive colonies with NLS enrichment.  
Because we were unable to identify any positive colonies, it is difficult to conclude if the 
differences between the two laboratories were the cause of the differences in targeting 
efficiencies or if a larger number of colonies are need to identify a positive target.   
 A comparison of colony survival to analysis and the number of colonies per 
million cells transfected between the GT1 experiments when looked at from promoter 
trap—lipofection vs. electroporation and polyA trap—lipofection vs. electroporation 
shows a 100% survival rate of all lipofected colonies while only 22% promoter trap and 
52% polyA trap electroporated colonies survived to analysis.  In addition, lipofection 
was more favorable to growth with 0.5 and 0.25 colonies per million cells for promoter 
trap and polyA trap compared to 0.02 and 0.06 colonies in electroporation of the 
constructs.  The differences in the numbers of colonies surviving lipofection can be 
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explained by the more favorable nature of this form of transfection over electroporation.  
Lipofection involves the transfer of DNA through the cell membrane via endocytosis of 
a DNA-lipid complex (186) while electroporation relies on an electric field to create 
transient holes in the cell membrane (187).  While too few cells were subjected to 
lipofection to draw any definite conclusions, sufficient cell numbers were electroporated 
to show the predicted three-fold increase in colonies expected in the polyA trap 
compared to promoter trap constructs.  The presence of an NLS in the GT1-NLS 
construct dramatically reduced the number of cells surviving selection as compared to 
the GT1 promoter trap electroporations.  While the number of cells electroporated was 
sufficient to expect colonies, the lack of colonies with the GT1-NLS with or without 
thymidine further supports the trend seen with the GT2-NLS plasmid (as compared to 
Dai et al. (72) results) in the NLS signal’s ability to reducing the number of colonies. 
 The presence of an IRES greatly increases the number of colonies due to its 
ability to allow for cap-independent translation of the selectable marker located directly 
downstream.  In essence, the researcher loses some of the power associated with a 
promoter trap when an IRES is used in the construct.  If the targeting construct 
incorporates into any actively transcribed gene, the IRES will allow for translation 
regardless of the position of the start codon of the selectable marker.  The addition of the 
IRES is necessary in some cases when the endogenous promoter of the gene of interest is 
weak and can not drive enough selectable marker product to allow for survival of the 
correctly targeted cells.  Because Harrison et al. (73) found the GT promoter activity 
insufficient to drive GFP expression, the addition of an IRES in the targeting construct is 
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probably warranted.  However, Harrison et al. (73) successfully used a fusion neomycin 
resistant gene without an IRES but their construct utilized a different area of the GT 
gene and therefore may lead to different targeting efficiencies.  Further support to a 
promoterless neomycin resistant gene’s ability to protect the cell was given by Hanson 
and Sedivy (188) who achieved a 4% targeting efficiency in an immortal rat fibroblast 
cell line using a relatively weak c-myc gene promoter trap construct.  The c-myc 
promoter activity was sufficient to drive neomycin resistance despite the presence of 33 
times more G418 than normally used.  If the GT promoter is a weak expresser, the lack 
of an IRES in the GT1 (promoterless puromycin) constructs could hinder the ability of 
the puromycin resistant gene to elicit protection making it impossible to identify any 
positively targeted colonies. 
 Overall, these results suggest that the use of a promoterless puromycin resistant 
gene may not be the best choice for use in targeting the GT gene.  The choice of 
puromycin instead of neomycin/G418 for selection was made mainly because of 
puromycin’s ability to kill cells more quickly and therefore lead to less background in 
culture and lessen the amounts of mixed (both transgenic and non-transgenic) 
populations of cells in the surviving colonies.  However, puromycin is probably too 
powerful a selection molecule to use when the weaker GT promoter drives the resistant 
gene and therefore targeted colonies may have died during selection despite using the 
lowest possible concentration of puromycin.  In order to use puromycin for selection 
with low active promoters a new, more efficient puromycin resistant gene needs to be 
developed.  The use of a promoterless neomycin resistant gene without an IRES has 
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been successful and fewer colonies arise because of the lack of the IRES.  However, 
because of the chance of either the fusion protein not functioning properly of the 
endogenous promoter not being strong enough, the use of an IRES in the targeting 
construct is warranted at least in the preliminary experiments. 
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CHAPTER VI 
 
SUMMARY AND CONCLUSIONS 
 
 
 The ability to precisely modify the genome of livestock species will have 
profound effects in both the fields of agriculture and human medicine.  The successful 
attempts made thus far are very encouraging.  The current protocols used are not 
efficient enough to make targeting in livestock a routine technique.  Because of the large 
expense of raising, maintaining, and breeding livestock, protocols that increase the 
efficiency of targeting are of the utmost importance.  The aim of these experiments was 
to develop an efficient HR system for the pig.   
 HR in somatic cells is a complex and poorly understood phenomenon.  The first 
study attempted to manipulate the somewhat simpler NHEJ pathway in order to 
indirectly up-regulate HR.  Three molecules were chosen to study; Mre11, Ku70/80, and 
p53.  Unfortunately, manipulation of the Mre11 and the Ku proteins did not increase HR 
between the two truncated plasmids.  Mutation of the p53 protein did show significant 
improvement of HR, however, tight control must be exerted on the transient nature of 
the p53 gene due to the tendency of mutated p53 cells to become aneuploid thus limiting 
the application of the cells.   
 Another major obstacle to overcome in the use of normal somatic fibroblasts in 
targeting experiments is their finite lifespan.  Human fibroblasts have been made to by-
pass senescence by the addition of hTERT.  Transformation of PFFs with the same 
hTERT did not extend lifespan.  Also, cells high in telomerase activity have higher rates 
of HR.  To test whether telomerase expression, in itself, caused this increase in HR, 
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PFFs expressing hTERT were compared to control PFFs not expressing hTERT in their 
ability to recombine two truncated plasmids.  There was no increase found, however, 
given the fact that hTERT did not increase the lifespan of PFFs it is unclear whether 
hTERT functions in the same manner in PFFs as porcine telomerase.  Once a porcine 
TERT is isolated and shown to function correctly, these experiments should be repeated 
to elucidate an important aspect of HR.  As an added benefit, extension of the lifespan of 
PFFs while maintaining normal karyotypes, as shown with hTERT expressing human 
fibroblasts, will greatly facilitate the selection process possibly making two rounds of 
selection possible.  This will dramatically decrease the time and expense of making a 
homozygous knockout animal.   
 As another way to improve HR, the time of the cell cycle as well as efficient 
DNA nuclear delivery was studied.  Thymidine treatment was used to synchronize the 
cells in late S phase and an NLS-bearing protein recognition signal was added to the two 
truncated plasmids.  Improvement of HR resulted in each situation with a slight additive 
affect using both.  HR is most active in the late S phase of the cell cycle; therefore, 
synchronizing the cells allows for more cells to be receptive to repairing the DSBs in this 
fashion over that of NHEJ.  Thymidine, however, has the potential to harm the cells as 
seen by the poor quality of the cells after treatment and the lower survival after 
electroporation.  Studies determining other, less detrimental, late S phase synchronizing 
agents should enhance the efficiency of HR.  Other DNA delivery mechanisms such as 
lipofection could also help to alleviate some of the harmful affects of thymidine 
treatment.  The expedient delivery of the plasmid to the nucleus lessens the time in the 
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cytoplasm where it can be rapidly degraded by various nucleases, as well as extending 
the time of plasmid exposure to the HR machinery in the nucleus also increases the rates 
of HR.  The NLS signal used in the experiments functioned well.  The use of this or 
other more specific (i.e. protective, cell cycle specific, etc.) NLS recognition signals 
should help to further the gene targeting efficiency.   
 Finally, because of the discrepancies sometimes seen when results from plasmid 
to plasmid (extra-chromosomal) recombination experiments are applied to targeting 
(inter-chromosomal) protocols, the enhancer protocols were applied to the targeting of 
the GT locus.  Extensive experiments using a promoterless puromycin resistant gene 
were undertaken.  Comparatively few colonies survived to analysis and none were 
deemed positive.  One promising colony was used for cloning and resulted in the birth of 
eight healthy transgenic piglets.  Puromycin may be too powerful a selection agent to use 
when a relatively weak promoter such as the GT is used to drive the expression of the 
currently available resistant gene.  Development of a more potent puromycin resistant 
gene could facilitate the use of this selection agent in future targeting projects. 
 The use of an NLS signal and thymidine synchronization greatly reduced the 
number of colonies surviving selection over that of a similar construct used by Dai (72).  
Three of these colonies were promising, but due to the finite lifespan of the fibroblasts, 
sufficient growth to isolate enough DNA for a genomic Southern blot was impossible.  
Therefore, a definitive answer to whether a gene targeting event took place is not 
possible.  Cloning of these colonies to produce fetuses or live piglets would enable the 
collection of tissue on which a genomic Southern blot could be performed.  In addition, 
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more transfections need to be performed to determine a definitive answer as to whether 
the enhancers do indeed work for gene targeting as they do with the plasmid to plasmid 
systems.  The results could also be locus dependent.  In related experiments the use of 
the NLS and thymidine synchronization resulted in increased rates of HR at the HPRT 
locus in bovine fetal fibroblasts (Mir and Piedrahita unpublished observations). 
 The ability to achieve gene targeting using livestock somatic cells is a powerful 
tool.  Studies on the basic mechanisms involved in HR and NHEJ as well as the 
development of protocols to manipulate other aspects that indirectly affect the rates of 
HR (i.e. telomerase, cell cycle, and DNA delivery) will benefit all aspects of biological 
science.  More efficient protocols will allow for targeting techniques to be used by 
laboratories that would normally not undertake such studies due to its current inherent 
difficulties.        
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